CINXE.COM

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml" xmlns:dc="http://purl.org/dc/terms/" xmlns:doi="http://dx.doi.org/" lang="en" xml:lang="en" itemscope itemtype="http://schema.org/Article" class="no-js"> <head prefix="og: http://ogp.me/ns#"> <link rel="stylesheet" href="/resource/css/screen.css?79f248ebefa43b7800a14562e5049ab4"/>   <link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,600"> <link media="print" rel="stylesheet" type="text/css" href="/resource/css/print.css"/> <script type="text/javascript"> var siteUrlPrefix = "/plosone/"; </script> <script src="/resource/js/vendor/modernizr-v2.7.1.js" type="text/javascript"></script> <script src="/resource/js/vendor/detectizr.min.js" type="text/javascript"></script> <link rel="shortcut icon" href="/resource/img/favicon.ico" type="image/x-icon"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link rel="canonical" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202604" /> <meta name="description" content="We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30–60 mL/min/1.73 m2 or overt proteinuria in the presence of an eGFR>60 mL/min/1.73 m2. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use." /> <meta name="citation_abstract" content="We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30–60 mL/min/1.73 m2 or overt proteinuria in the presence of an eGFR>60 mL/min/1.73 m2. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use."> <meta name="keywords" content="Blood pressure,Hypertension,Chronic kidney disease,Antihypertensives,Nephrology,Diuretics,Resistant hypertension,Antihypertensive drugs" /> <meta name="citation_doi" content="10.1371/journal.pone.0202604"/> <meta name="citation_author" content="Markus P. Schneider"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, Klinikum Nürnberg, Paracelsus Private Medical University, Nürnberg, Germany"/> <meta name="citation_author" content="Karl F. Hilgers"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author" content="Matthias Schmid"/> <meta name="citation_author_institution" content="Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), University of Bonn, Bonn, Germany"/> <meta name="citation_author" content="Silvia Hübner"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author" content="Jennifer Nadal"/> <meta name="citation_author_institution" content="Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), University of Bonn, Bonn, Germany"/> <meta name="citation_author" content="David Seitz"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author" content="Martin Busch"/> <meta name="citation_author_institution" content="Department of Internal Medicine III, University Hospital Jena, Friedrich-Schiller-Universität, Jena, Germany"/> <meta name="citation_author" content="Hermann Haller"/> <meta name="citation_author_institution" content="Division of Nephrology, Hannover Medical School, Hannover, Germany"/> <meta name="citation_author" content="Anna Köttgen"/> <meta name="citation_author_institution" content="Division of Genetic Epidemiology, Institute for Biometry and Statistics, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany"/> <meta name="citation_author" content="Florian Kronenberg"/> <meta name="citation_author_institution" content="Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria"/> <meta name="citation_author" content="Seema Baid-Agrawal"/> <meta name="citation_author_institution" content="Department of Nephrology and Medical Intensive Care, Charité –Universitätsmedizin Berlin, Berlin, Germany"/> <meta name="citation_author" content="Georg Schlieper"/> <meta name="citation_author_institution" content="Department of Nephrology and Clinical Immunology, RWTH Aachen, Aachen, Germany"/> <meta name="citation_author" content="Ulla Schultheiss"/> <meta name="citation_author_institution" content="Division of Genetic Epidemiology, Institute for Biometry and Statistics, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany"/> <meta name="citation_author_institution" content="Division of Nephrology, University of Freiburg, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany"/> <meta name="citation_author" content="Thomas Sitter"/> <meta name="citation_author_institution" content="Department of Nephrology, University Hospital, Ludwig-Maximilians-Universität München, München, Germany"/> <meta name="citation_author" content="Claudia Sommerer"/> <meta name="citation_author_institution" content="Department of Nephrology, University of Heidelberg, Heidelberg, Germany"/> <meta name="citation_author" content="Stephanie Titze"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author" content="Heike Meiselbach"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author" content="Christoph Wanner"/> <meta name="citation_author_institution" content="Division of Nephrology, Department of Medicine, University Hospital of Würzburg, Würzburg, Germany"/> <meta name="citation_author" content="Kai-Uwe Eckardt"/> <meta name="citation_author_institution" content="Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany"/> <meta name="citation_author_institution" content="Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria"/> <meta name="citation_author" content="for the GCKD Study Investigators"/> <meta name="citation_title" content="Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study"/> <meta itemprop="name" content="Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study"/> <meta name="citation_journal_title" content="PLOS ONE"/> <meta name="citation_journal_abbrev" content="PLOS ONE"/> <meta name="citation_date" content="Aug 20, 2018"/> <meta name="citation_firstpage" content="e0202604"/> <meta name="citation_issue" content="8"/> <meta name="citation_volume" content="13"/> <meta name="citation_issn" content="1932-6203"/> <meta name="citation_publisher" content="Public Library of Science"/> <meta name="citation_pdf_url" content="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0202604&type=printable"> <meta name="citation_article_type" content="Research Article"> <meta name="dc.identifier" content="10.1371/journal.pone.0202604" /> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="plosone"/> <meta name="twitter:title" content="Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study" /> <meta property="twitter:description" content="We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30–60 mL/min/1.73 m2 or overt proteinuria in the presence of an eGFR>60 mL/min/1.73 m2. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use." /> <meta property="twitter:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0202604.g005&size=inline" /> <meta property="og:type" content="article" /> <meta property="og:url" content="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0202604"/> <meta property="og:title" content="Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study"/> <meta property="og:description" content="We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30–60 mL/min/1.73 m2 or overt proteinuria in the presence of an eGFR>60 mL/min/1.73 m2. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use."/> <meta property="og:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0202604.g005&size=inline"/> <meta name="citation_reference" content="citation_title=Evolving importance of kidney disease: from subspecialty to global health burden;citation_author=KU Eckardt;citation_author=J Coresh;citation_author=O Devuyst;citation_author=RJ Johnson;citation_author=A Kottgen;citation_author=AS Levey;citation_journal_title=Lancet;citation_volume=382;citation_number=382;citation_issue=9887;citation_first_page=158;citation_last_page=69;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=Chronic kidney disease;citation_author=AS Levey;citation_author=J Coresh;citation_journal_title=Lancet;citation_volume=379;citation_number=379;citation_issue=9811;citation_first_page=165;citation_last_page=80;citation_publication_date=2012;"/> <meta name="citation_reference" content="citation_title=Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention;citation_author=RT Gansevoort;citation_author=R Correa-Rotter;citation_author=BR Hemmelgarn;citation_author=TH Jafar;citation_author=HJ Heerspink;citation_author=JF Mann;citation_journal_title=Lancet;citation_volume=382;citation_number=382;citation_issue=9889;citation_first_page=339;citation_last_page=52;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=The double challenge of resistant hypertension and chronic kidney disease;citation_author=P Rossignol;citation_author=ZA Massy;citation_author=M Azizi;citation_author=G Bakris;citation_author=E Ritz;citation_author=A Covic;citation_journal_title=Lancet;citation_volume=386;citation_number=386;citation_issue=10003;citation_first_page=1588;citation_last_page=98;citation_publication_date=2015;"/> <meta name="citation_reference" content="citation_title=What should be the goal blood pressure in nondiabetic chronic kidney disease?;citation_author=MP Schneider;citation_author=KF Hilgers;citation_journal_title=Current opinion in nephrology and hypertension;citation_volume=23;citation_number=23;citation_issue=2;citation_first_page=180;citation_last_page=5;citation_publication_date=2014;"/> <meta name="citation_reference" content="citation_title=Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease;citation_author=DC Wheeler;citation_author=GJ Becker;citation_journal_title=Kidney international;citation_volume=83;citation_number=83;citation_issue=3;citation_first_page=377;citation_last_page=83;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=A Randomized Trial of Intensive versus Standard Blood-Pressure Control;citation_author=SR Group;citation_author=JT Wright Jr.;citation_author=JD Williamson;citation_author=PK Whelton;citation_author=JK Snyder;citation_author=KM Sink;citation_journal_title=The New England journal of medicine;citation_volume=373;citation_number=373;citation_issue=22;citation_first_page=2103;citation_last_page=16;citation_publication_date=2015;"/> <meta name="citation_reference" content="citation_title=Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT;citation_author=GM Chertow;citation_author=S Beddhu;citation_author=JB Lewis;citation_author=RD Toto;citation_author=AK Cheung;citation_journal_title=Journal of the American Society of Nephrology: JASN;citation_volume=27;citation_number=27;citation_issue=1;citation_first_page=40;citation_last_page=3;citation_publication_date=2016;"/> <meta name="citation_reference" content="citation_title=How Does SPRINT (Systolic Blood Pressure Intervention Trial) Direct Hypertension Treatment Targets for CKD?;citation_author=SJ Taler;citation_journal_title=American journal of kidney diseases: the official journal of the National Kidney Foundation;citation_publication_date=2016;"/> <meta name="citation_reference" content="citation_title=KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease;citation_author=KBPW Group;citation_journal_title=Kidney Int Suppl;citation_volume=2;citation_number=2;citation_first_page=337;citation_last_page=414;citation_publication_date=2012;"/> <meta name="citation_reference" content="citation_title=Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension;citation_journal_title=Journal of hypertension;citation_volume=31;citation_number=31;citation_issue=10;citation_first_page=1925;citation_last_page=38;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8);citation_author=PA James;citation_author=S Oparil;citation_author=BL Carter;citation_author=WC Cushman;citation_author=C Dennison-Himmelfarb;citation_author=J Handler;citation_journal_title=Jama;citation_volume=311;citation_number=311;citation_issue=5;citation_first_page=507;citation_last_page=20;citation_publication_date=2014;"/> <meta name="citation_reference" content="citation_title=Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study;citation_author=P Muntner;citation_author=A Anderson;citation_author=J Charleston;citation_author=Z Chen;citation_author=V Ford;citation_author=G Makos;citation_journal_title=National Kidney Foundation;citation_volume=55;citation_number=55;citation_issue=3;citation_first_page=441;citation_last_page=51;citation_publication_date=2010;"/> <meta name="citation_reference" content="citation_title=Control of hypertension in adults with chronic kidney disease in the United States;citation_author=CA Peralta;citation_author=LS Hicks;citation_author=GM Chertow;citation_author=JZ Ayanian;citation_author=E Vittinghoff;citation_author=F Lin;citation_journal_title=Hypertension;citation_volume=45;citation_number=45;citation_issue=6;citation_first_page=1119;citation_last_page=24;citation_publication_date=2005;"/> <meta name="citation_reference" content="citation_title=Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study;citation_author=MJ Landray;citation_author=JR Emberson;citation_author=L Blackwell;citation_author=T Dasgupta;citation_author=R Zakeri;citation_author=MD Morgan;citation_journal_title=American journal of kidney diseases: the official journal of the National Kidney Foundation;citation_volume=56;citation_number=56;citation_issue=6;citation_first_page=1082;citation_last_page=94;citation_publication_date=2010;"/> <meta name="citation_reference" content="citation_title=Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study;citation_author=A Martinez-Castelao;citation_author=JL Gorriz;citation_author=JM Portoles;citation_author=F De Alvaro;citation_author=A Cases;citation_author=J Luno;citation_journal_title=BMC nephrology;citation_volume=12;citation_number=12;citation_first_page=53;citation_publication_date=2011;"/> <meta name="citation_reference" content="citation_title=The German Chronic Kidney Disease (GCKD) study: design and methods;citation_author=KU Eckardt;citation_author=B Barthlein;citation_author=S Baid-Agrawal;citation_author=A Beck;citation_author=M Busch;citation_author=F Eitner;citation_journal_title=Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association;citation_volume=27;citation_number=27;citation_issue=4;citation_first_page=1454;citation_last_page=60;citation_publication_date=2012;"/> <meta name="citation_reference" content="citation_title=Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort;citation_author=S Titze;citation_author=M Schmid;citation_author=A Kottgen;citation_author=M Busch;citation_author=J Floege;citation_author=C Wanner;citation_journal_title=Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association;citation_volume=30;citation_number=30;citation_issue=3;citation_first_page=441;citation_last_page=51;citation_publication_date=2015;"/> <meta name="citation_reference" content="citation_title=Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function;citation_author=E Imai;citation_author=S Matsuo;citation_author=H Makino;citation_author=T Watanabe;citation_author=T Akizawa;citation_author=K Nitta;citation_journal_title=Clinical and experimental nephrology;citation_volume=14;citation_number=14;citation_issue=6;citation_first_page=558;citation_last_page=70;citation_publication_date=2010;"/> <meta name="citation_reference" content="citation_title=Hypertension awareness, treatment, and control in chronic kidney disease;citation_author=PA Sarafidis;citation_author=S Li;citation_author=SC Chen;citation_author=AJ Collins;citation_author=WW Brown;citation_author=MJ Klag;citation_journal_title=The American journal of medicine;citation_volume=121;citation_number=121;citation_issue=4;citation_first_page=332;citation_last_page=40;citation_publication_date=2008;"/> <meta name="citation_reference" content="citation_title=Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006;citation_author=LC Plantinga;citation_author=ER Miller 3rd;citation_author=LA Stevens;citation_author=R Saran;citation_author=K Messer;citation_author=N Flowers;citation_journal_title=Hypertension;citation_volume=54;citation_number=54;citation_issue=1;citation_first_page=47;citation_last_page=56;citation_publication_date=2009;"/> <meta name="citation_reference" content="citation_title=Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study;citation_author=R Marin;citation_author=F Fernandez-Vega;citation_author=M Gorostidi;citation_author=LM Ruilope;citation_author=J Diez;citation_author=M Praga;citation_journal_title=Journal of hypertension;citation_volume=24;citation_number=24;citation_issue=2;citation_first_page=395;citation_last_page=402;citation_publication_date=2006;"/> <meta name="citation_reference" content="citation_title=Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort;citation_author=T Konta;citation_author=A Ikeda;citation_author=K Ichikawa;citation_author=S Fujimoto;citation_author=K Iseki;citation_author=T Moriyama;citation_journal_title=American journal of hypertension;citation_volume=25;citation_number=25;citation_issue=3;citation_first_page=342;citation_last_page=7;citation_publication_date=2012;"/> <meta name="citation_reference" content="citation_title=Germany: Health system review;citation_author=R Busse;citation_author=M Blumel;citation_journal_title=Health systems in transition;citation_volume=16;citation_number=16;citation_issue=2;citation_first_page=1;citation_last_page=296;citation_publication_date=2014;"/> <meta name="citation_reference" content="citation_title=Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study;citation_author=G Thomas;citation_author=D Xie;citation_author=HY Chen;citation_author=AH Anderson;citation_author=LJ Appel;citation_author=S Bodana;citation_journal_title=Hypertension;citation_volume=67;citation_number=67;citation_issue=2;citation_first_page=387;citation_last_page=96;citation_publication_date=2016;"/> <meta name="citation_reference" content="citation_title=Measuring, analyzing, and managing drug adherence in resistant hypertension;citation_author=M Burnier;citation_author=G Wuerzner;citation_author=H Struijker-Boudier;citation_author=J Urquhart;citation_journal_title=Hypertension;citation_volume=62;citation_number=62;citation_issue=2;citation_first_page=218;citation_last_page=25;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=Resistant hypertension? Assessment of adherence by toxicological urine analysis;citation_author=O Jung;citation_author=JL Gechter;citation_author=C Wunder;citation_author=A Paulke;citation_author=C Bartel;citation_author=H Geiger;citation_journal_title=Journal of hypertension;citation_volume=31;citation_number=31;citation_issue=4;citation_first_page=766;citation_last_page=74;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study;citation_author=P Muntner;citation_author=SE Judd;citation_author=M Krousel-Wood;citation_author=WM McClellan;citation_author=MM Safford;citation_journal_title=American journal of kidney diseases: the official journal of the National Kidney Foundation;citation_volume=56;citation_number=56;citation_issue=3;citation_first_page=447;citation_last_page=57;citation_publication_date=2010;"/> <meta name="citation_reference" content="citation_title=Adherence to antihypertensive agents and blood pressure control in chronic kidney disease;citation_author=KE Schmitt;citation_author=CF Edie;citation_author=P Laflam;citation_author=LA Simbartl;citation_author=CV Thakar;citation_journal_title=American journal of nephrology;citation_volume=32;citation_number=32;citation_issue=6;citation_first_page=541;citation_last_page=8;citation_publication_date=2010;"/> <meta name="citation_reference" content="citation_title=Drug adherence in chronic kidney diseases and dialysis;citation_author=M Burnier;citation_author=M Pruijm;citation_author=G Wuerzner;citation_author=V Santschi;citation_journal_title=Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association;citation_volume=30;citation_number=30;citation_issue=1;citation_first_page=39;citation_last_page=44;citation_publication_date=2015;"/> <meta name="citation_reference" content="citation_title=Cardiorenal end points in a trial of aliskiren for type 2 diabetes;citation_author=HH Parving;citation_author=BM Brenner;citation_author=JJ McMurray;citation_author=D de Zeeuw;citation_author=SM Haffner;citation_author=SD Solomon;citation_journal_title=The New England journal of medicine;citation_volume=367;citation_number=367;citation_issue=23;citation_first_page=2204;citation_last_page=13;citation_publication_date=2012;"/> <meta name="citation_reference" content="citation_title=Combined angiotensin inhibition for the treatment of diabetic nephropathy;citation_author=LF Fried;citation_author=N Emanuele;citation_author=JH Zhang;citation_author=M Brophy;citation_author=TA Conner;citation_author=W Duckworth;citation_journal_title=The New England journal of medicine;citation_volume=369;citation_number=369;citation_issue=20;citation_first_page=1892;citation_last_page=903;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey;citation_author=KB Sonawane;citation_author=J Qian;citation_author=RA Hansen;citation_journal_title=Clinical therapeutics;citation_volume=37;citation_number=37;citation_issue=1;citation_first_page=188;citation_last_page=96;citation_publication_date=2015;"/> <meta name="citation_reference" content="citation_title=Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. American journal of kidney diseases: the official journal of the;citation_author=M Gorostidi;citation_author=PA Sarafidis;citation_author=A de la Sierra;citation_author=J Segura;citation_author=JJ de la Cruz;citation_author=JR Banegas;citation_journal_title=National Kidney Foundation;citation_volume=62;citation_number=62;citation_issue=2;citation_first_page=285;citation_last_page=94;citation_publication_date=2013;"/> <meta name="citation_reference" content="citation_title=Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage;citation_author=PE Drawz;citation_author=AB Alper;citation_author=AH Anderson;citation_author=CS Brecklin;citation_author=J Charleston;citation_author=J Chen;citation_journal_title=Clinical journal of the American Society of Nephrology: CJASN;citation_publication_date=2016;"/>  <script type='text/javascript'> var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; (function() { var gads = document.createElement('script'); gads.async = true; gads.type = 'text/javascript'; var useSSL = 'https:' == document.location.protocol; gads.src = (useSSL ? 'https:' : 'http:') + '//www.googletagservices.com/tag/js/gpt.js'; var node = document.getElementsByTagName('script')[0]; node.parentNode.insertBefore(gads, node); })(); </script>  <script id="doubleClickSetupScript" type='text/javascript'> googletag.cmd.push(function() { googletag.defineSlot('/75507958/PONE_728x90_ATF', [728, 90], 'div-gpt-ad-1458247671871-0').addService(googletag.pubads()); googletag.defineSlot('/75507958/PONE_160x600_BTF', [160, 600], 'div-gpt-ad-1458247671871-1').addService(googletag.pubads()); var personalizedAds = window.plosCookieConsent && window.plosCookieConsent.hasConsented('advertising'); googletag.pubads().setRequestNonPersonalizedAds(personalizedAds ? 0 : 1); googletag.pubads().enableSingleRequest(); googletag.enableServices(); }); </script> <script type="text/javascript"> var WombatConfig = WombatConfig || {}; WombatConfig.journalKey = "PLoSONE"; WombatConfig.journalName = "PLOS ONE"; WombatConfig.figurePath = "/plosone/article/figure/image"; WombatConfig.figShareInstitutionString = "plos"; WombatConfig.doiResolverPrefix = "https://dx.plos.org/"; </script> <script type="text/javascript"> var WombatConfig = WombatConfig || {}; WombatConfig.metrics = WombatConfig.metrics || {}; WombatConfig.metrics.referenceUrl = "http://lagotto.io/plos"; WombatConfig.metrics.googleScholarUrl = "https://scholar.google.com/scholar"; WombatConfig.metrics.googleScholarCitationUrl = WombatConfig.metrics.googleScholarUrl + "?hl=en&lr=&q="; WombatConfig.metrics.crossrefUrl = "https://www.crossref.org"; </script> <script defer="defer" src="/resource/js/defer.js?13928eb59791c3cc61cf"></script><script src="/resource/js/sync.js?13928eb59791c3cc61cf"></script> <script src="/resource/js/vendor/jquery.min.js" type="text/javascript"></script> <script type="text/javascript" src="https://widgets.figshare.com/static/figshare.js"></script> <script src="/resource/js/vendor/fastclick/lib/fastclick.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.js" type="text/javascript"></script> <script src="/resource/js/vendor/underscore-min.js" type="text/javascript"></script> <script src="/resource/js/vendor/underscore.string.min.js" type="text/javascript"></script> <script src="/resource/js/vendor/moment.js" type="text/javascript"></script> <script src="/resource/js/vendor/jquery-ui-effects.min.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.tooltip.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.tab.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.reveal.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.slider.js" type="text/javascript"></script> <script src="/resource/js/util/utils.js" type="text/javascript"></script> <script src="/resource/js/components/toggle.js" type="text/javascript"></script> <script src="/resource/js/components/truncate_elem.js" type="text/javascript"></script> <script src="/resource/js/components/tooltip_hover.js" type="text/javascript"></script> <script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>  <script> dataLayer = [{ 'mobileSite': 'false', 'desktopSite': 'true' }]; </script> <title>Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study | PLOS ONE</title> </head> <body class="article plosone">  <noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-TP26BH" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <script> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-TP26BH'); </script> <noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQQMGF" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MQQMGF');</script>   <script type="text/javascript"> ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(32),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(33),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),P=t(15),S=t(10),M=t("ee"),N=M.get("tracer"),C=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),S.on(p,r),M.on(d,o),b.on(l,o),S.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),P.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),N.buffer([u,"no-"+u]),S.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(S,"new-jsonp"),a(S,"jsonp-end"),a(S,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,C(!0)),w[v]("load",i,C(!0)),w[v]("popstate",function(){i(0,U>1)},C(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(33),a=t(32);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(32),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(29),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=NREUM.o.REQ,y=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof y&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;"string"==typeof i?n=i:"object"==typeof i&&i instanceof g?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n);var s=(""+(i&&i instanceof g&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}),u.on("fetch-done",function(t,e){this.endTime=a.now(),this.params||(this.params={}),this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(32),s=t(33),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(34);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t){return!(!t||!t.protocol||"file:"===t.protocol)}e.exports=r},{}],28:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?p("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&p("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(c&&c<r.startTime)return;p("lcp",[r])}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||p("cls",[t])})}function a(t){if(t instanceof v&&!g){var e=Math.round(t.timeStamp),n={type:t.type};e<=l.now()?n.fid=l.now()-e:e>l.offset&&e<=Date.now()?(e-=l.offset,n.fid=l.now()-e):e=l.now(),g=!0,p("timing",["fi",e,n])}}function s(t){"hidden"===t&&(c=l.now(),p("pageHide",[c]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var c,f,u,d,p=t("handle"),l=t("loader"),h=t(31),m=t(23),v=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){f=new PerformanceObserver(r);try{f.observe({entryTypes:["paint"]})}catch(w){}u=new PerformanceObserver(o);try{u.observe({entryTypes:["largest-contentful-paint"]})}catch(w){}d=new PerformanceObserver(i);try{d.observe({type:"layout-shift",buffered:!0})}catch(w){}}if("addEventListener"in document){var g=!1,y=["click","keydown","mousedown","pointerdown","touchstart"];y.forEach(function(t){document.addEventListener(t,a,m(!1))})}h(s)}},{}],29:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],30:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],31:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],32:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],33:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],34:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(32),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!P++){var t=T.info=NREUM.info,e=v.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(R,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+T.offset],null,"api"),s("timing",["load",n]);var r=v.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=h+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===v.readyState&&i()}function i(){s("mark",["domContent",a()+T.offset],null,"api")}var a=t(26),s=t("handle"),c=t(32),f=t("ee"),u=t(30),d=t(27),p=t(21),l=t(23),h=p.getConfiguration("ssl")===!1?"http":"https",m=window,v=m.document,w="addEventListener",g="attachEvent",y=m.XMLHttpRequest,x=y&&y.prototype,b=!d(m.location);NREUM.o={ST:setTimeout,SI:m.setImmediate,CT:clearTimeout,XHR:y,REQ:m.Request,EV:m.Event,PR:m.Promise,MO:m.MutationObserver};var E=""+location,R={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1212.min.js"},O=y&&x&&x[w]&&!/CriOS/.test(navigator.userAgent),T=e.exports={offset:a.getLastTimestamp(),now:a,origin:E,features:{},xhrWrappable:O,userAgent:u,disabled:b};if(!b){t(20),t(28),v[w]?(v[w]("DOMContentLoaded",i,l(!1)),m[w]("load",r,l(!1))):(v[g]("onreadystatechange",o),m[g]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var P=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(33),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]); ;NREUM.loader_config={accountID:"804283",trustKey:"804283",agentID:"402703674",licenseKey:"cf99e8d2a3",applicationID:"402703674"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"cf99e8d2a3", // Modified this value from the generated script, to pass prod vs dev applicationID: window.location.hostname.includes('journals.plos.org') ? "402703674" : "402694889", sa:1} </script>  <header> <div id="topslot" class="head-top"> <a id="skip-to-content" tabindex="0" class="button" href="#main-content"> Skip to main content </a> <div class="center"> <div class="title">Advertisement</div>  <div class='advertisement' id='div-gpt-ad-1458247671871-0' style='width:728px; height:90px;'> <script type='text/javascript'> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-0'); }); </script> </div> </div> </div> <div id="user" class="nav" data-user-management-url="https://community.plos.org"> </div> <div id="pagehdr"> <nav class="nav-main"> <h1 class="logo"> <a href="/plosone/.">PLOS ONE</a> </h1> <section class="top-bar-section"> <ul class="nav-elements"> <li class="multi-col-parent menu-section-header has-dropdown" id="publish"> Publish <div class="dropdown mega "> <ul class="multi-col" id="publish-dropdown-list"> <li class="menu-section-header " id="submissions"> <span class="menu-section-header-title"> Submissions </span> <ul class="menu-section " id="submissions-dropdown-list"> <li> <a href="/plosone/s/getting-started" >Getting Started</a> </li> <li> <a href="/plosone/s/submission-guidelines" >Submission Guidelines</a> </li> <li> <a href="/plosone/s/figures" >Figures</a> </li> <li> <a href="/plosone/s/tables" >Tables</a> </li> <li> <a href="/plosone/s/supporting-information" >Supporting Information</a> </li> <li> <a href="/plosone/s/latex" >LaTeX</a> </li> <li> <a href="/plosone/s/what-we-publish" >What We Publish</a> </li> <li> <a href="/plosone/s/preprints" >Preprints</a> </li> <li> <a href="/plosone/s/revising-your-manuscript" >Revising Your Manuscript</a> </li> <li> <a href="/plosone/s/submit-now" >Submit Now</a> </li> <li> <a href="https://collections.plos.org/s/calls-for-papers" >Calls for Papers</a> </li> </ul> </li> <li class="menu-section-header " id="policies"> <span class="menu-section-header-title"> Policies </span> <ul class="menu-section " id="policies-dropdown-list"> <li> <a href="/plosone/s/best-practices-in-research-reporting" >Best Practices in Research Reporting</a> </li> <li> <a href="/plosone/s/human-subjects-research" >Human Subjects Research</a> </li> <li> <a href="/plosone/s/animal-research" >Animal Research</a> </li> <li> <a href="/plosone/s/competing-interests" >Competing Interests</a> </li> <li> <a href="/plosone/s/disclosure-of-funding-sources" >Disclosure of Funding Sources</a> </li> <li> <a href="/plosone/s/licenses-and-copyright" >Licenses and Copyright</a> </li> <li> <a href="/plosone/s/data-availability" >Data Availability</a> </li> <li> <a href="/plosone/s/complementary-research" >Complementary Research</a> </li> <li> <a href="/plosone/s/materials-software-and-code-sharing" >Materials, Software and Code Sharing</a> </li> <li> <a href="/plosone/s/ethical-publishing-practice" >Ethical Publishing Practice</a> </li> <li> <a href="/plosone/s/authorship" >Authorship</a> </li> <li> <a href="/plosone/s/corrections-expressions-of-concern-and-retractions" >Corrections, Expressions of Concern, and Retractions</a> </li> </ul> </li> <li class="menu-section-header " id="manuscript-review-and-publication"> <span class="menu-section-header-title"> Manuscript Review and Publication </span> <ul class="menu-section " id="manuscript-review-and-publication-dropdown-list"> <li> <a href="/plosone/s/criteria-for-publication" >Criteria for Publication</a> </li> <li> <a href="/plosone/s/editorial-and-peer-review-process" >Editorial and Peer Review Process</a> </li> <li> <a href="https://plos.org/resources/editor-center" >Editor Center</a> </li> <li> <a href="/plosone/s/resources-for-editors" >Resources for Editors</a> </li> <li> <a href="/plosone/s/reviewer-guidelines" >Guidelines for Reviewers</a> </li> <li> <a href="/plosone/s/accepted-manuscripts" >Accepted Manuscripts</a> </li> <li> <a href="/plosone/s/comments" >Comments</a> </li> </ul> </li> </ul> <div class="calloutcontainer"> <h3 class="callout-headline">Submit Your Manuscript</h3> <div class="action-contain"> <p class="callout-content"> Discover a faster, simpler path to publishing in a high-quality journal. <em>PLOS ONE</em> promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time. </p> <p class="button-contain special"> <a class="button button-default" href="/plosone/static/publish"> Learn More </a> <a class="button-link" href="https://www.editorialmanager.com/pone/default.asp"> Submit Now </a> </p> </div>  </div> </div> </li> <li class="menu-section-header has-dropdown " id="about"> <span class="menu-section-header-title"> About </span> <ul class="menu-section dropdown " id="about-dropdown-list"> <li> <a href="/plosone/static/publish" >Why Publish with PLOS ONE</a> </li> <li> <a href="/plosone/s/journal-information" >Journal Information</a> </li> <li> <a href="/plosone/s/staff-editors" >Staff Editors</a> </li> <li> <a href="/plosone/static/editorial-board" >Editorial Board</a> </li> <li> <a href="/plosone/s/section-editors" >Section Editors</a> </li> <li> <a href="/plosone/s/advisory-groups" >Advisory Groups</a> </li> <li> <a href="/plosone/s/find-and-read-articles" >Find and Read Articles</a> </li> <li> <a href="/plosone/s/publishing-information" >Publishing Information</a> </li> <li> <a href="https://plos.org/publication-fees" >Publication Fees</a> </li> <li> <a href="https://plos.org/press-and-media" >Press and Media</a> </li> <li> <a href="/plosone/s/contact" >Contact</a> </li> </ul> </li> <li data-js-tooltip-hover="trigger" class="subject-area menu-section-header"> Browse </li> <script src="/resource/js/vendor/jquery.hoverIntent.js" type="text/javascript"></script> <script src="/resource/js/components/menu_drop.js" type="text/javascript"></script> <script src="/resource/js/components/hover_delay.js" type="text/javascript"></script> <li id="navsearch" class="head-search"> <form name="searchForm" action="/plosone/search" method="get"> <fieldset> <legend>Search</legend> <label for="search">Search</label> <div class="search-contain"> <input id="search" type="text" name="q" placeholder="SEARCH" required/> <button id="headerSearchButton" type="submit" aria-label="Submit search"> <i title="Submit search" class="search-icon"></i> </button> </div> </fieldset> <input type="hidden" name="filterJournals" value="PLoSONE"/> </form> <a id="advSearch" href="/plosone/search"> advanced search </a> <script src="/resource/js/components/placeholder_style.js" type="text/javascript"></script> </li> </ul> </section> </nav> </div> </header> <section id="taxonomyContainer"> <script src="/resource/js/taxonomy-browser.js" type="text/javascript"></script> <div id="taxonomy-browser" class="areas" data-search-url="/plosone/browse"> <div class="wrapper"> <div class="taxonomy-header"> Browse Subject Areas <div id="subjInfo">?</div> <div id="subjInfoText"> <p>Click through the PLOS taxonomy to find articles in your field.</p> <p>For more information about PLOS Subject Areas, click <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>. </p> </div> </div> <div class="levels"> <div class="levels-container cf"> <div class="levels-position"></div> </div> <a href="#" class="prev"></a> <a href="#" class="next active"></a> </div> </div> <div class="taxonomy-browser-border-bottom"></div> </div> </section> <main id="main-content"> <div class="set-grid"> <header class="title-block"> <script src="/resource/js/components/signposts.js" type="text/javascript"></script> <ul id="almSignposts" class="signposts"> <li id="loadingMetrics"> <p>Loading metrics</p> </li> </ul> <script type="text/template" id="signpostsGeneralErrorTemplate"> <li id="metricsError">Article metrics are unavailable at this time. Please try again later.</li> </script> <script type="text/template" id="signpostsNewArticleErrorTemplate"> <li></li><li></li><li id="tooSoon">Article metrics are unavailable for recently published articles.</li> </script> <script type="text/template" id="signpostsTemplate"> <li id="almSaves"> <%= s.numberFormat(saveCount, 0) %> <div class="tools" data-js-tooltip-hover="trigger"> <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#savedHeader">Save</a> <p class="saves-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#savedHeader">Total Mendeley and Citeulike bookmarks.</a></p> </div> </li> <li id="almCitations"> <%= s.numberFormat(citationCount, 0) %> <div class="tools" data-js-tooltip-hover="trigger"> <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#citedHeader">Citation</a> <p class="citations-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#citedHeader">Paper's citation count computed by Dimensions.</a></p> </div> </li> <li id="almViews"> <%= s.numberFormat(viewCount, 0) %> <div class="tools" data-js-tooltip-hover="trigger"> <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#viewedHeader">View</a> <p class="views-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#viewedHeader">PLOS views and downloads.</a></p> </div> </li> <li id="almShares"> <%= s.numberFormat(shareCount, 0) %> <div class="tools" data-js-tooltip-hover="trigger"> <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#discussedHeader">Share</a> <p class="shares-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0202604#discussedHeader">Sum of Facebook, Twitter, Reddit and Wikipedia activity.</a></p> </div> </li> </script> <div class="article-meta"> <div class="classifications"> <p class="license-short" id="licenseShort">Open Access</p> <p class="peer-reviewed" id="peerReviewed">Peer-reviewed</p> <div class="article-type" > <p class="type-article" id="artType">Research Article</p> </div> </div> </div> <div class="article-title-etc"> <div class="title-authors"> <h1 id="artTitle"><?xml version="1.0" encoding="UTF-8"?>Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study</h1> <ul class="author-list clearfix" data-js-tooltip="tooltip_container" id="author-list"> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="0" class="author-name" > Markus P. Schneider <span class="email"> </span>,</a> <div id="author-meta-0" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Investigation, Project administration, Writing – review & editing </p> <p id="authCorresponding-0"> <span class="email">* E-mail:</span> <a href="mailto:markus.schneider@uk-erlangen.de">markus.schneider@uk-erlangen.de</a></p> <p id="authAffiliations-0"><span class="type">Affiliations</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany, Department of Nephrology and Hypertension, Klinikum Nürnberg, Paracelsus Private Medical University, Nürnberg, Germany </p> <div> <p class="orcid" id="authOrcid-0"> <span> <a id="connect-orcid-link" href="http://orcid.org/0000-0002-5265-8088" target="_blank" title="ORCID Registry"> <img id="orcid-id-logo" src="/resource/img/orcid_16x16.png" width="16" height="16" alt="ORCID logo"/> http://orcid.org/0000-0002-5265-8088 </a> </span> </p> </div> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose0"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="1" class="author-name" > Karl F. Hilgers,</a> <div id="author-meta-1" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Investigation, Writing – original draft </p> <p id="authAffiliations-1"><span class="type">Affiliation</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose1"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="2" class="author-name" > Matthias Schmid,</a> <div id="author-meta-2" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Data curation, Formal analysis, Methodology, Software </p> <p id="authAffiliations-2"><span class="type">Affiliation</span> Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), University of Bonn, Bonn, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose2"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="3" class="author-name" > Silvia Hübner,</a> <div id="author-meta-3" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Investigation </p> <p id="authAffiliations-3"><span class="type">Affiliation</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose3"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="4" class="author-name" > Jennifer Nadal,</a> <div id="author-meta-4" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Data curation, Formal analysis, Software, Visualization </p> <p id="authAffiliations-4"><span class="type">Affiliation</span> Department of Medical Biometry, Informatics, and Epidemiology (IMBIE), University of Bonn, Bonn, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose4"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="5" class="author-name" > David Seitz,</a> <div id="author-meta-5" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Investigation </p> <p id="authAffiliations-5"><span class="type">Affiliation</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose5"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="6" class="author-name" > Martin Busch,</a> <div id="author-meta-6" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-6"><span class="type">Affiliation</span> Department of Internal Medicine III, University Hospital Jena, Friedrich-Schiller-Universität, Jena, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose6"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="7" class="author-name" > Hermann Haller,</a> <div id="author-meta-7" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-7"><span class="type">Affiliation</span> Division of Nephrology, Hannover Medical School, Hannover, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose7"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="8" class="author-name" > Anna Köttgen,</a> <div id="author-meta-8" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-8"><span class="type">Affiliation</span> Division of Genetic Epidemiology, Institute for Biometry and Statistics, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose8"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="9" class="author-name" > Florian Kronenberg,</a> <div id="author-meta-9" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-9"><span class="type">Affiliation</span> Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose9"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="10" class="author-name" > Seema Baid-Agrawal,</a> <div id="author-meta-10" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-10"><span class="type">Affiliation</span> Department of Nephrology and Medical Intensive Care, Charité –Universitätsmedizin Berlin, Berlin, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose10"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="11" class="author-name" > Georg Schlieper,</a> <div id="author-meta-11" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-11"><span class="type">Affiliation</span> Department of Nephrology and Clinical Immunology, RWTH Aachen, Aachen, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose11"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="12" class="author-name" > Ulla Schultheiss,</a> <div id="author-meta-12" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-12"><span class="type">Affiliations</span> Division of Genetic Epidemiology, Institute for Biometry and Statistics, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany, Division of Nephrology, University of Freiburg, Faculty of Medicine and Medical Center—University of Freiburg, Freiburg, Germany </p> <div> <p class="orcid" id="authOrcid-12"> <span> <a id="connect-orcid-link" href="http://orcid.org/0000-0002-7541-5310" target="_blank" title="ORCID Registry"> <img id="orcid-id-logo" src="/resource/img/orcid_16x16.png" width="16" height="16" alt="ORCID logo"/> http://orcid.org/0000-0002-7541-5310 </a> </span> </p> </div> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose12"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" data-js-toggle="toggle_target" data-visibility= "none" > <a data-author-id="13" class="author-name" > Thomas Sitter,</a> <div id="author-meta-13" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-13"><span class="type">Affiliation</span> Department of Nephrology, University Hospital, Ludwig-Maximilians-Universität München, München, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose13"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" data-js-toggle="toggle_target" data-visibility= "none" > <a data-author-id="14" class="author-name" > Claudia Sommerer,</a> <div id="author-meta-14" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-14"><span class="type">Affiliation</span> Department of Nephrology, University of Heidelberg, Heidelberg, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose14"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" data-js-toggle="toggle_target" data-visibility= "none" > <a data-author-id="15" class="author-name" > Stephanie Titze,</a> <div id="author-meta-15" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Project administration </p> <p id="authAffiliations-15"><span class="type">Affiliation</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany </p> <div> <p class="orcid" id="authOrcid-15"> <span> <a id="connect-orcid-link" href="http://orcid.org/0000-0002-4886-6511" target="_blank" title="ORCID Registry"> <img id="orcid-id-logo" src="/resource/img/orcid_16x16.png" width="16" height="16" alt="ORCID logo"/> http://orcid.org/0000-0002-4886-6511 </a> </span> </p> </div> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose15"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" data-js-toggle="toggle_target" data-visibility= "none" > <a data-author-id="16" class="author-name" > Heike Meiselbach,</a> <div id="author-meta-16" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Project administration </p> <p id="authAffiliations-16"><span class="type">Affiliation</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose16"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" data-js-toggle="toggle_target" data-visibility= "none" > <a data-author-id="17" class="author-name" > Christoph Wanner,</a> <div id="author-meta-17" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Writing – review & editing </p> <p id="authAffiliations-17"><span class="type">Affiliation</span> Division of Nephrology, Department of Medicine, University Hospital of Würzburg, Würzburg, Germany </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose17"> ⨯ </a> </div> </li> <li data-js-tooltip="tooltip_trigger" data-js-toggle="toggle_target" data-visibility= "none" > <a data-author-id="18" class="author-name" > Kai-Uwe Eckardt,</a> <div id="author-meta-18" class="author-info" data-js-tooltip="tooltip_target"> <p class="roles" id="authRoles"> <span class="type">Roles</span> Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Writing – review & editing </p> <p id="authAffiliations-18"><span class="type">Affiliations</span> Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany, Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria </p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose18"> ⨯ </a> </div> </li> <li data-js-toggle="toggle_add"> [ ... ],</li> <li data-js-tooltip="tooltip_trigger" > <a data-author-id="19" class="author-name" > for the GCKD Study Investigators <span class="rel-footnote"> </span></a> <div id="author-meta-19" class="author-info" data-js-tooltip="tooltip_target"> <p><span class="rel-footnote">¶</span>The current GCKD investigators are listed in the Acknowledgments.</p> <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose19"> ⨯ </a> </div> </li> <li data-js-toggle="toggle_trigger" > <a class="more-authors active" id="authors-show">[ view all ]</a> </li> <li data-js-toggle="toggle_trigger" data-visibility="none"> <a class="author-less" id="author-hide">[ view less ]</a> </li> </ul> <script src="/resource/js/components/tooltip.js" type="text/javascript"></script> </div> <div id="floatTitleTop" data-js-floater="title_author" class="float-title" role="presentation"> <div class="set-grid"> <div class="float-title-inner"> <h1><?xml version="1.0" encoding="UTF-8"?>Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study</h1> <ul id="floatAuthorList" data-js-floater="floated_authors"> <li data-float-index="1">Markus P. Schneider,  </li> <li data-float-index="2">Karl F. Hilgers,  </li> <li data-float-index="3">Matthias Schmid,  </li> <li data-float-index="4">Silvia Hübner,  </li> <li data-float-index="5">Jennifer Nadal,  </li> <li data-float-index="6">David Seitz,  </li> <li data-float-index="7">Martin Busch,  </li> <li data-float-index="8">Hermann Haller,  </li> <li data-float-index="9">Anna Köttgen,  </li> <li data-float-index="10">Florian Kronenberg </ul> </div> <div class="logo-close" id="titleTopCloser"> <img src="/resource/img/logo-plos.png" style="height: 2em" alt="PLOS" /> <div class="close-floater" title="close">x</div> </div> </div> </div> <ul class="date-doi"> <li id="artPubDate">Published: August 20, 2018</li> <li id="artDoi"> <a href="https://doi.org/10.1371/journal.pone.0202604">https://doi.org/10.1371/journal.pone.0202604</a> </li> <li class="flex-spacer"></li> </ul> </div> <div> </div> </header> <section class="article-body"> <ul class="article-tabs"> <li class="tab-title active" id="tabArticle"> <a href="/plosone/article?id=10.1371/journal.pone.0202604" class="article-tab-1">Article</a> </li> <li class="tab-title " id="tabAuthors"> <a href="/plosone/article/authors?id=10.1371/journal.pone.0202604" class="article-tab-2">Authors</a> </li> <li class="tab-title " id="tabMetrics"> <a href="/plosone/article/metrics?id=10.1371/journal.pone.0202604" class="article-tab-3">Metrics</a> </li> <li class="tab-title " id="tabComments"> <a href="/plosone/article/comments?id=10.1371/journal.pone.0202604" class="article-tab-4">Comments</a> </li> <li class="tab-title" id="tabRelated"> <a class="article-tab-5" id="tabRelated-link">Media Coverage</a> <script>$(document).ready(function() { $.getMediaLink("10.1371/journal.pone.0202604").then(function (url) { $("#tabRelated-link").attr("href", url) } ) })</script> </li> </ul> <div class="article-container"> <div id="nav-article"> <ul class="nav-secondary"> <li class="nav-comments" id="nav-comments"> <a href="article/comments?id=10.1371/journal.pone.0202604">Reader Comments</a> </li> <li id="nav-figures"><a href="#" data-doi="10.1371/journal.pone.0202604">Figures</a></li> </ul> <div id="nav-data-linking" data-data-url=""> </div> </div> <script src="/resource/js/components/scroll.js" type="text/javascript"></script> <script src="/resource/js/components/nav_builder.js" type="text/javascript"></script> <script src="/resource/js/components/floating_nav.js" type="text/javascript"></script> <div id="figure-lightbox-container"></div> <script id="figure-lightbox-template" type="text/template"> <div id="figure-lightbox" class="reveal-modal full" data-reveal aria-hidden="true" role="dialog"> <div class="lb-header"> <h1 id="lb-title"><%= articleTitle %></h1> <div id="lb-authors"> <span>Markus P. Schneider</span> <span>Karl F. Hilgers</span> <a class="more-authors" href="/plosone/article/authors?id=10.1371/journal.pone.0202604">...</a> <span>for the GCKD Study Investigators</span> </div> <div class="lb-close" title="close"> </div> </div> <div class="img-container"> <div class="loader"> <i class="fa-spinner"></i> </div> <img class="main-lightbox-image" src=""/> <aside id="figures-list"> <% figureList.each(function (ix, figure) { %> <div class="change-img" data-doi="<%= figure.getAttribute('data-doi') %>"> <img class="aside-figure" src="/plosone/article/figure/image?size=inline&id=<%= figure.getAttribute('data-doi') %>" /> </div> <% }) %> <div class="dummy-figure"> </div> </aside> </div> <div id="lightbox-footer"> <div id="btns-container" class="lightbox-row <% if(figureList.length <= 1) { print('one-figure-only') } %>"> <div class="fig-btns-container reset-zoom-wrapper left"> <span class="fig-btn reset-zoom-btn">Reset zoom</span> </div> <div class="zoom-slider-container"> <div class="range-slider-container"> <span id="lb-zoom-min"></span> <div class="range-slider round" data-slider data-options="start: 20; end: 200; initial: 20;"> <span class="range-slider-handle" role="slider" tabindex="0"></span> <span class="range-slider-active-segment"></span> <input type="hidden"> </div> <span id="lb-zoom-max"></span> </div> </div> <% if(figureList.length > 1) { %> <div class="fig-btns-container"> <span class="fig-btn all-fig-btn"><i class="icon icon-all"></i> All Figures</span> <span class="fig-btn next-fig-btn"><i class="icon icon-next"></i> Next</span> <span class="fig-btn prev-fig-btn"><i class="icon icon-prev"></i> Previous</span> </div> <% } %> </div> <div id="image-context"> </div> </div> </div> </script> <script id="image-context-template" type="text/template"> <div class="footer-text"> <div id="figure-description-wrapper"> <div id="view-more-wrapper" style="<% descriptionExpanded? print('display:none;') : '' %>"> <span id="figure-title"><%= title %></span> <p id="figure-description"> <%= description %>   </p> <span id="view-more">show more<i class="icon-arrow-right"></i></span> </div> <div id="view-less-wrapper" style="<% descriptionExpanded? print('display:inline-block;') : '' %>" > <span id="figure-title"><%= title %></span> <p id="full-figure-description"> <%= description %>   <span id="view-less">show less<i class="icon-arrow-left"></i></span> </p> </div> </div> </div> <div id="show-context-container"> <a class="btn show-context" href="<%= showInContext(strippedDoi) %>">Show in Context</a> </div> <div id="download-buttons"> <h3>Download:</h3> <div class="item"> <a href="/plosone/article/figure/image?size=original&download=&id=<%= doi %>" title="original image"> <span class="download-btn">TIFF</span> </a> <span class="file-size"><%= fileSizes.original %></span> </div> <div class="item"> <a href="/plosone/article/figure/image?size=large&download=&id=<%= doi %>" title="large image"> <span class="download-btn">PNG</span> </a> <span class="file-size"><%= fileSizes.large %></span> </div> <div class="item"> <a href="/plosone/article/figure/powerpoint?id=<%= doi %>" title="PowerPoint slide"> <span class="download-btn">PPT</span> </a> </div> </div> </script> <div class="article-content"> <div class="amendment amendment-correction toc-section"> <a data-toc="amendment-0" title="Correction" id="amendment-0" name="amendment-0"></a> <h2>Correction</h2> <div class="amendment-citation"> <p> <span class="amendment-date"> 13 Sep 2018: </span> Schneider MP, Hilgers KF, Schmid M, Hübner S, Nadal J, et al. (2018) <?xml version="1.0" encoding="UTF-8"?>Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study. PLOS ONE 13(9): e0204340. <a href="https://doi.org/10.1371/journal.pone.0204340">https://doi.org/10.1371/journal.pone.0204340</a> <span class="link-separator"> </span> <a href="/plosone/article?id=10.1371/journal.pone.0204340" class="amendment-link"> View correction </a> </p> </div> </div> <div id="figure-carousel-section"> <h2>Figures</h2> <div id="figure-carousel"> <div class="carousel-wrapper"> <div class="slider"> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.g001"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g001" loading="lazy" alt="Fig 1" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.t001"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.t001" loading="lazy" alt="Table 1" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.g002"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g002" loading="lazy" alt="Fig 2" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.t002"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.t002" loading="lazy" alt="Table 2" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.g003"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g003" loading="lazy" alt="Fig 3" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.g004"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g004" loading="lazy" alt="Fig 4" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.t003"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.t003" loading="lazy" alt="Table 3" /> </div> <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0202604.g005"> <img src="/plosone/article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g005" loading="lazy" alt="Fig 5" /> </div> </div> </div> <div class="carousel-control"> <span class="button previous"></span> <span class="button next"></span> </div> <div class="carousel-page-buttons"> </div> </div> </div> <script src="/resource/js/vendor/jquery.touchswipe.js" type="text/javascript"></script> <script src="/resource/js/components/figure_carousel.js" type="text/javascript"></script> <script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script> <div class="article-text" id="artText"> <div xmlns:plos="http://plos.org" class="abstract toc-section abstract-type-"><a id="abstract0" name="abstract0" data-toc="abstract0" class="link-target" title="Abstract"></a><h2>Abstract</h2><div class="abstract-content"><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1" class="link-target"></a><p>We assessed the prevalence, awareness, treatment and control of hypertension in patients with moderate chronic kidney disease (CKD) under nephrological care in Germany. In the German Chronic Kidney Disease (GCKD) study, 5217 patients under nephrology specialist care were enrolled from 2010 to 2012 in a prospective observational cohort study. Inclusion criteria were an estimated glomerular filtration rate (eGFR) of 30–60 mL/min/1.73 m<sup>2</sup> or overt proteinuria in the presence of an eGFR>60 mL/min/1.73 m<sup>2</sup>. Office blood pressure was measured by trained study personnel in a standardized way and hypertension awareness and medication were assessed during standardized interviews. Blood pressure was considered as controlled if systolic < 140 and diastolic < 90 mmHg. In 5183 patients in whom measurements were available, mean blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg; 4985 (96.2%) of the patients were hypertensive. Awareness and treatment rates were > 90%. However, only 2456 (49.3%) of the hypertensive patients had controlled blood pressure. About half (51.0%) of the patients with uncontrolled blood pressure met criteria for resistant hypertension. Factors associated with better odds for controlled blood pressure in multivariate analyses included younger age, female sex, higher income, low or absent proteinuria, and use of certain classes of antihypertensive medication. We conclude that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use.</p> </div></div> <div xmlns:plos="http://plos.org" class="articleinfo"><p><strong>Citation: </strong>Schneider MP, Hilgers KF, Schmid M, Hübner S, Nadal J, Seitz D, et al. (2018) Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study. PLoS ONE 13(8): e0202604. https://doi.org/10.1371/journal.pone.0202604</p><p><strong>Editor: </strong>Tatsuo Shimosawa, International University of Health and Welfare, School of Medicine, JAPAN</p><p><strong>Received: </strong>June 22, 2018; <strong>Accepted: </strong>August 5, 2018; <strong>Published: </strong> August 20, 2018</p><p><strong>Copyright: </strong> © 2018 Schneider et al. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Data Availability: </strong>All relevant data are within the paper.</p><p><strong>Funding: </strong>The GCKD study is funded by grants from the German Ministry of Education and Research (BMBF) (<a href="http://www.gesundheitsforschung-bmbf.de">www.gesundheitsforschung-bmbf.de</a>; grant numbers 01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821, and 01ER 0122) and the KfH Foundation for Preventive Medicine (<a href="http://www.kfh-stiftung-praeventivmedizin.de/">http://www.kfh-stiftung-praeventivmedizin.de/</a>) to K-UE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p><p><strong>Competing interests: </strong> The authors have declared that no competing interests exist.</p></div> <div xmlns:plos="http://plos.org" id="section1" class="section toc-section"><a id="sec001" name="sec001" data-toc="sec001" class="link-target" title="Introduction"></a><h2>Introduction</h2><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1" class="link-target"></a><p>Chronic kidney disease (CKD) has been increasingly recognized as a global health burden [<a href="#pone.0202604.ref001" class="ref-tip">1</a>, <a href="#pone.0202604.ref002" class="ref-tip">2</a>]. The prevalence of CKD is 10–15% in the general adult population in both high- and low-income countries. Individuals with CKD are at risk for progressive loss of kidney function and kidney failure requiring renal replacement therapy. In addition, the presence of CKD worsens the prognosis of many non-renal diseases. In particular, CKD has been recognized as a major cardiovascular risk factor [<a href="#pone.0202604.ref003" class="ref-tip">3</a>].</p> <a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2" class="link-target"></a><p>Blood pressure control is considered a mainstay of CKD management, in order to alleviate the progressive loss of kidney function, as well as to lower the risk of cardiovascular disease [<a href="#pone.0202604.ref004" class="ref-tip">4</a>]. The controversial discussion about optimal blood pressure targets in CKD patients [<a href="#pone.0202604.ref005" class="ref-tip">5</a>, <a href="#pone.0202604.ref006" class="ref-tip">6</a>] has recently been rekindled by the results of the SPRINT trial in which 28% of enrolled patients had CKD [<a href="#pone.0202604.ref007" class="ref-tip">7</a>]. Several authors now recommend to lower blood pressure goals in patients with CKD [<a href="#pone.0202604.ref008" class="ref-tip">8</a>, <a href="#pone.0202604.ref009" class="ref-tip">9</a>]. All recent guidelines developed prior to publication of the SPRINT trial propose maintaining blood pressure at least below 140/90 mmHg in all CKD patients [<a href="#pone.0202604.ref010" class="ref-tip">10</a>–<a href="#pone.0202604.ref012" class="ref-tip">12</a>]. For patients with CKD and proteinuria above 300 mg/L, most guidelines [<a href="#pone.0202604.ref010" class="ref-tip">10</a>, <a href="#pone.0202604.ref011" class="ref-tip">11</a>] suggest lower blood pressure targets, although the evidence supporting this suggestion is limited [<a href="#pone.0202604.ref005" class="ref-tip">5</a>, <a href="#pone.0202604.ref006" class="ref-tip">6</a>]. Despite these recommendations, studies from large population-based surveys and CKD cohorts in the United States [<a href="#pone.0202604.ref013" class="ref-tip">13</a>, <a href="#pone.0202604.ref014" class="ref-tip">14</a>] as well as from western European countries [<a href="#pone.0202604.ref015" class="ref-tip">15</a>, <a href="#pone.0202604.ref016" class="ref-tip">16</a>] have shown rather poor rates of blood pressure control.</p> <a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3" class="link-target"></a><p>We enrolled >5200 patients treated by nephrologists into the German Chronic Kidney Disease (GCKD) study, a long-term observational cohort study [<a href="#pone.0202604.ref017" class="ref-tip">17</a>]. A cross-sectional overview of patient characteristics at baseline [<a href="#pone.0202604.ref018" class="ref-tip">18</a>] showed rather high blood pressure levels, despite the fact that >80% of patients had been under nephrology specialist care for at least 1 year. To better understand the limitations of blood pressure control in this population we have therefore analyzed associations with comorbidities, sociodemographic factors, medication patterns and the presence of resistant hypertension. Our results describe the diversity of blood pressure control and overall emphasize the need to alleviate the burden of hypertension in CKD patients.</p> </div> <div xmlns:plos="http://plos.org" id="section2" class="section toc-section"><a id="sec002" name="sec002" data-toc="sec002" class="link-target" title="Materials and methods"></a><h2>Materials and methods</h2> <div id="section1" class="section toc-section"><a id="sec003" name="sec003" class="link-target" title="Study participants"></a> <h3>Study participants</h3> <a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1" class="link-target"></a><p>The design of the study has been previously published in detail [<a href="#pone.0202604.ref017" class="ref-tip">17</a>]. The GCKD study was registered in a national database of clinical studies (“Deutsches Register für Klinische Studien”, DRKS 00003971), and was approved by the ethics committees of all participating centers (Friedrich Alexander University of Erlangen-Nuremberg, University of Freiburg, Ludwig-MaximiliansUniversity of Munich, University of Hannover, Charité –Universitätsmedizin Berlin, University of Würzburg, University of Aachen, University of Jena, Heidelberg University). Caucasian patients could be included into the study if age was 18 to 74 years, and if they met at least one of two criteria: a) an estimated glomerular filtration rate (eGFR) between 30 and 60 ml/min/1.73 m<sup>2</sup> or b) manifest proteinuria (urinary protein/creatinine >500 mg/g or equivalent) if eGFR was >60 ml/min/1.73 m<sup>2</sup>. Patients were not able to participate if they previously underwent solid organ or bone marrow transplantation, had suffered a malignancy, had advanced heart failure, were under legal attendance or not able to provide informed consent. Written informed consent was obtained from all participants prior to their enrolment.</p> </div> <div id="section2" class="section toc-section"><a id="sec004" name="sec004" class="link-target" title="Examinations performed"></a> <h3>Examinations performed</h3> <a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1" class="link-target"></a><p>The patients were examined by certified study nurses in the regional GCKD centers or in the nephrology practices of the participating nephrologists. The training of study nurses included the correct and standardized conduct of blood pressure measurements. Prior to the blood pressure measurements, upper arm circumference was determined in order to use the correct cuff size (small, medium, large and extra-large cuffs were available). Blood pressure was measured in a sitting position after 5 min of rest with an oscillometric device (Omron M5 Professional devices). Three measurements were taken in the presence of the study nurse (“observed measurements”) with two minutes between each measurement. The mean of the three measurements went into the current analysis. No specific instructions were given with regard to caffeine or tobacco intake on the day of the study visit. In addition, detailed information on the medical history and sociodemographic factors was obtained. Definitions of co-morbidities etc. were used according to international standards [<a href="#pone.0202604.ref018" class="ref-tip">18</a>]. Information on the precise type of any medication (prescribed and over the counter) was collected, but dosage and intake schedules were not recorded. Substances were classified using the WHO’s Anatomical Therapeutic Chemical (ATC) classification (<a href="http://www.whocc.no/">http://www.whocc.no/</a>). For the purpose of our analysis, all antihypertensive medications were grouped into the following 7 main categories: (1) inhibitors of the renin-angiotensin system (RAS; comprising the 3 sub-categories ACE inhibitors, AT1 blockers, and renin inhibitors); (2) diuretics (comprising the 3 sub-categories thiazide diuretics, loop diuretics, and potassium-sparing diuretics including aldosterone blockers), (3) beta blockers, (4) central sympatholytic agents, (5) peripheral acting alpha-adrenergic antagonists, (6) calcium channel blockers, and (7) other vasodilators. All data presented in this manuscript (including all blood pressure data and all covariates) were taken from the GCKD baseline visit.</p> </div> <div id="section3" class="section toc-section"><a id="sec005" name="sec005" class="link-target" title="Definitions of hypertension, awareness, control, and resistant hypertension"></a> <h3>Definitions of hypertension, awareness, control, and resistant hypertension</h3> <a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1" class="link-target"></a><p>Patients were considered “<strong>hypertensive</strong>” if the mean of the 3 blood pressure measurements was ≥ 140 mmHg systolic, or ≥ 90 mmHg diastolic, or if any antihypertensive drug was currently prescribed. A hypertensive patient was defined as “<strong>aware</strong>” of hypertension if he or she described him- or herself as hypertensive in the patient questionnaire during the interview. The blood pressure was defined as “<strong>controlled</strong>” if the mean of 3 recordings yielded < 140 mmHg systolic and < 90 mmHg diastolic in a patient classified as hypertensive. A hypertensive patient was considered to suffer from “<strong>resistant hypertension</strong>” if the mean of the 3 blood pressure measurements was ≥ 140 mmHg systolic, or ≥ 90 mmHg diastolic, despite a current medication with at least 3 different antihypertensive drugs, including a diuretic.</p> </div> <div id="section4" class="section toc-section"><a id="sec006" name="sec006" class="link-target" title="Statistical analysis"></a> <h3>Statistical analysis</h3> <a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1" class="link-target"></a><p>Data is described using means ± standard deviations (SD) for continuous variables and frequency distributions with percentages for categorical variables. Odds ratios with 95% confidence intervals were calculated to analyze the univariate associations (or lack thereof) of controlled blood pressure with a number of factors, including antihypertensive medications (i.e., the groups described above), age category (≥18- <45,≥ 45- < 65 and ≥65 years old), sex, marital status (single, married, divorced/separated, widowed), education, gross yearly income, type of health insurance (statutory or private), body mass index (underweight: BMI < 18.5; normal weight: BMI ≥18.5 to <25; overweight: BMI ≥25 to <30; obesity: BMI≥30), smoking status (non-smoker, former smoker, current smoker), self-reported ethanol intake, diabetes mellitus (absence or presence), previous cardiovascular, cerebrovascular or peripheral vascular disease, stratum of urine albumin-to-creatinine ratio (< 30 mg/g, ≥30- <300 mg/g, ≥ 300 mg/g), and eGFR stratum (≥60, ≥45-< 60, ≥30- <45, <30 ml/min/1.73m<sup>2</sup>) estimated according to the 4-variable Modification of Diet in Renal Disease formula [<a href="#pone.0202604.ref019" class="ref-tip">19</a>]. For multivariate analysis, adjusted odds ratios with 95% confidence intervals for all factors were calculated using the coefficient estimates obtained from binary logistic regression. A p-value < 0.05 was considered significant. Calculations were carried out using SAS Version 9.2 by SAS Institute Inc., Cary NC, USA.</p> </div> </div> <div xmlns:plos="http://plos.org" id="section3" class="section toc-section"><a id="sec007" name="sec007" data-toc="sec007" class="link-target" title="Results"></a><h2>Results</h2><a id="article1.body1.sec3.p1" name="article1.body1.sec3.p1" class="link-target"></a><p>Blood pressure data were available for analysis from 5183 participants. Mean ± SD blood pressure was 139.5 ± 20.4 / 79.3 ± 11.8 mmHg (N = 5183). The distribution of blood pressure levels in the entire cohort is shown in <a href="#pone-0202604-g001">Fig 1</a>. Mean blood pressure levels for subgroups defined by age, sex, eGFR stratum, proteinuria stratum and presence of diabetes are shown in <a href="#pone-0202604-t001">Table 1</a>. No fewer than 4985 of 5183 (96.2%) met the criteria for hypertension.</p> <a class="link-target" id="pone-0202604-g001" name="pone-0202604-g001"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.g001"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.g001" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.g001"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g001" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.g001"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.g001"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.g001"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Fig 1. </span> Frequency distribution of systolic (upper panel) and diastolic (lower panel) blood pressure in participants of the GCKD study.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.g001"> https://doi.org/10.1371/journal.pone.0202604.g001</a></p></div><a class="link-target" id="pone-0202604-t001" name="pone-0202604-t001"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.t001"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.t001" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.t001"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.t001" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.t001"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.t001"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.t001"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Table 1. </span> Blood pressure levels and control of blood pressure according to demographic, biometric and other factors.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.t001"> https://doi.org/10.1371/journal.pone.0202604.t001</a></p></div><a id="article1.body1.sec3.p2" name="article1.body1.sec3.p2" class="link-target"></a><p>In the univariate analysis, several factors were associated with the prevalence of hypertension but effects were rather small. For example, the prevalence rose with age from 91.6% in the 18–44 years group to 95.6% in the 45–64 years group and to 97.9% in the 65–74 years group. Effects of similar size were observed for gender (93.6% in women vs. 97.9% in men), education, income, eGFR and proteinuria stratum (higher prevalence in higher strata), body mass index, presence of diabetes (98.0% vs. 93.6% in non-diabetic patients) or history of cardiovascular disease. Remarkably, all subgroups in all analyses exhibited a prevalence of hypertension > 90% (except for two very small subgroups with < 100 participants: patients with gross yearly income in excess of 100.000 €, and patients with underweight).</p> <a id="article1.body1.sec3.p3" name="article1.body1.sec3.p3" class="link-target"></a><p>Disease awareness was high among hypertensive patients (4557 of 4985 hypertensive participants, i.e. 94.1%). <a href="#pone-0202604-g002">Fig 2</a> shows the awareness of hypertension according to control of hypertension and medication pattern. Patients with uncontrolled hypertension, and patients receiving multiple antihypertensive medications, had the highest rates of awareness. In contrast, hitherto untreated hypertensive patients (N = 127) with blood pressure levels ≥ 140 mmHg systolic or ≥ 90 mmHg diastolic exhibited low awareness.</p> <a class="link-target" id="pone-0202604-g002" name="pone-0202604-g002"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.g002"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.g002" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.g002"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g002" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.g002"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.g002"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.g002"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Fig 2. </span> Awareness of hypertension according to control of hypertension and medication pattern.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.g002"> https://doi.org/10.1371/journal.pone.0202604.g002</a></p></div><a id="article1.body1.sec3.p4" name="article1.body1.sec3.p4" class="link-target"></a><p><a href="#pone-0202604-t002">Table 2</a> summarizes the utilization of different classes of antihypertensive medications. The vast majority (97.4%, N = 4854) of the hypertensive patients received at least one antihypertensive drug; only 127 patients had a blood pressure > 140/90 mmHg, but were not treated with antihypertensive medication. Most hypertensive patients (80.4%, N = 4008) received some form of combination therapy: Two (22.3%, N = 1111), three (23.3%, N = 1159), or more than three (34.9%, N = 1738) different antihypertensive drugs.</p> <a class="link-target" id="pone-0202604-t002" name="pone-0202604-t002"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.t002"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.t002" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.t002"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.t002" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.t002"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.t002"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.t002"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Table 2. </span> Use of antihypertensive medications.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.t002"> https://doi.org/10.1371/journal.pone.0202604.t002</a></p></div><a id="article1.body1.sec3.p5" name="article1.body1.sec3.p5" class="link-target"></a><p>The control of hypertension, however, was rather low, despite the high awareness and treatment rates and the intense antihypertensive pharmacotherapy. Using the rather conservative blood pressure target level of < 140 mmHg systolic and < 90 mmHg diastolic, no fewer than 2529 of 4985 hypertensive patients (50.7%) failed to reach target levels. In most cases, the systolic component of blood pressure was not controlled (<a href="#pone-0202604-g003">Fig 3</a>). Reducing systolic blood pressure can be limited by the risk of a too low diastolic blood pressure. To assess the prevalence of very low diastolic pressure levels in this group, we plotted the diastolic blood pressure levels of the 1596 patients with uncontrolled systolic but controlled diastolic blood pressure (<a href="#pone-0202604-g004">Fig 4</a>). However, only 230 patients in this group had a diastolic blood pressure < 70 mmHg, suggesting that diastolic blood pressure level was not a main hurdle for intensification of blood pressure lowering in most patients with isolated systolic hypertension. In fact, roughly half of them had a diastolic blood pressure between 80 and 90 mmHg and a low diastolic blood pressure would not have been a hindrance for further blood pressure lowering.</p> <a class="link-target" id="pone-0202604-g003" name="pone-0202604-g003"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.g003"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.g003" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.g003"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g003" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.g003"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.g003"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.g003"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Fig 3. </span> Control of blood pressure in hypertensive participants of the GCKD study.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.g003"> https://doi.org/10.1371/journal.pone.0202604.g003</a></p></div><a class="link-target" id="pone-0202604-g004" name="pone-0202604-g004"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.g004"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.g004" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.g004"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g004" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.g004"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.g004"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.g004"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Fig 4. </span> Frequency distribution of diastolic blood pressure levels of the 1596 patients with uncontrolled systolic but controlled diastolic blood pressure.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.g004"> https://doi.org/10.1371/journal.pone.0202604.g004</a></p></div><a id="article1.body1.sec3.p6" name="article1.body1.sec3.p6" class="link-target"></a><p>In the univariate analysis (<a href="#pone-0202604-t003">Table 3</a>), several factors were associated with a lower odds ratio for successful control of blood pressure: higher age, male sex, lower education, lower income, higher BMI, higher ethanol intake, presence of diabetes mellitus or peripheral vascular disease, higher strata of proteinuria and lower eGFR. In the multivariate analysis (<a href="#pone-0202604-t003">Table 3</a>), some factors remained significant, exhibiting clearly lower odds for control of blood pressure: higher age (OR 0.532 (0.411–0.690) for age ≥45≤65 versus ≥18≤45 and OR 0.379 (0.285–0.505) for age ≥65 versus ≥18≤45, <em>P</em><0.0001), male sex (OR 1.424 (1.208–1.678), <em>P</em><0.0001), lower income (OR 1.273 (1.082–1.498) for annual gross income 25.000–50.000 € versus <25.000 €, OR 1.286 (1.011–1.636) for 50.000–100.000 € versus <25.000 €, and OR 1.635 (0.968–2.762) for >100.000 € versus <25.000 €, <em>P</em> = 0.0134), and higher proteinuria (OR 0.735 (0.621–0.871) for albuminuria ≥30≤300 versus <30 mg/g and OR 0.488 (0.406–0.587) for ≥300 versus <30 mg/g, <em>P</em><0.0001). In contrast, eGFR strata, education, BMI, ethanol intake and presence of diabetes mellitus were no longer associated with blood pressure control in the multivariate analysis.</p> <a class="link-target" id="pone-0202604-t003" name="pone-0202604-t003"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.t003"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.t003" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.t003"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.t003" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.t003"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.t003"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.t003"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Table 3. </span> Association of blood pressure control with demographic, biometric, pharmacologic and other factors.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.t003"> https://doi.org/10.1371/journal.pone.0202604.t003</a></p></div><a id="article1.body1.sec3.p7" name="article1.body1.sec3.p7" class="link-target"></a><p>Also, we analyzed the medication pattern with regard to the control of blood pressure (<a href="#pone-0202604-g005">Fig 5</a>). Patients with controlled hypertension more often used 1–3 antihypertensive medications than patients with uncontrolled hypertension. In contrast, patients with uncontrolled hypertension more often used 4 or more different antihypertensive medications than patients with controlled hypertension. Of the 2529 patients with uncontrolled hypertension, 1291 (51.0%) met the criteria for resistant hypertension (3 or more different antihypertensive medications including a diuretic). The multivariate logistic regression for control of blood pressure according to the medications used (<a href="#pone-0202604-t003">Table 3</a>) showed that RAS inhibitors and diuretics were associated with a better chance of control whereas alpha blockers and central sympatholytic agents appeared to be associated with a poorer chance of control.</p> <a class="link-target" id="pone-0202604-g005" name="pone-0202604-g005"></a><div class="figure" data-doi="10.1371/journal.pone.0202604.g005"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&id=10.1371/journal.pone.0202604.g005" data-doi="10.1371/journal.pone.0202604" data-uri="10.1371/journal.pone.0202604.g005"><img src="article/figure/image?size=inline&id=10.1371/journal.pone.0202604.g005" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download"> Download: <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0202604.g005"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&size=large&id=10.1371/journal.pone.0202604.g005"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&size=original&id=10.1371/journal.pone.0202604.g005"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Fig 5. </span> Number of different antihypertensive medications in patients with controlled or uncontrolled hypertension.</div><p class="caption_target"></p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0202604.g005"> https://doi.org/10.1371/journal.pone.0202604.g005</a></p></div></div> <div xmlns:plos="http://plos.org" id="section4" class="section toc-section"><a id="sec008" name="sec008" data-toc="sec008" class="link-target" title="Discussion"></a><h2>Discussion</h2><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1" class="link-target"></a><p>This cross-sectional analysis of a large cohort of CKD patients under nephrology specialist care in Germany confirmed the near universal prevalence of hypertension in CKD patients. Despite very high rates of hypertension awareness and treatment, the latter mostly employing combination pharmacotherapy with several antihypertensive drugs, the control of hypertension was disappointing: Only 49.3% of our patients reached the conservative blood pressure goal of < 140/90 mmHg. Analysis of medication patterns indicated that 51.0% of patients with uncontrolled blood pressure (i.e. one quarter of the study population) met the criteria for resistant hypertension.</p> <a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2" class="link-target"></a><p>The very high prevalence of hypertension in CKD is not unexpected and in agreement with previous reports from similar cohorts of CKD patients in high-income countries, e.g. Japan [<a href="#pone.0202604.ref019" class="ref-tip">19</a>], Spain [<a href="#pone.0202604.ref016" class="ref-tip">16</a>], the U.K. [<a href="#pone.0202604.ref015" class="ref-tip">15</a>], and the U.S. [<a href="#pone.0202604.ref013" class="ref-tip">13</a>]. Although some sociodemographic factors and comorbidities were associated with prevalence rates of uncontrolled hypertension in a statistically significant manner, these effects were generally small, and even the sub-groups with a lower prevalence of hypertension still exhibited a prevalence of uncontrolled hypertension of 90% or more. While unawareness of hypertension is a well-known obstacle for blood pressure control in the general population, rates of hypertension awareness and treatment were high in the present cohort, as reported in other CKD cohorts [<a href="#pone.0202604.ref013" class="ref-tip">13</a>, <a href="#pone.0202604.ref016" class="ref-tip">16</a>, <a href="#pone.0202604.ref020" class="ref-tip">20</a>]. This observation renders the relatively low percentage of patients with controlled blood pressure all the more disappointing.</p> <a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3" class="link-target"></a><p>Rates of control of blood pressure in CKD cohorts vary widely. For example, the investigators of the U.S. Chronic Renal Insufficiency Cohort (CRIC) study reported that 67.1% of their patients had blood pressure levels < 140/90 mmHg [<a href="#pone.0202604.ref013" class="ref-tip">13</a>]. In contrast, a large cohort of CKD patients in a different setting in the U.S. described blood pressure control < 140/90 mmHg in only 11–21% of the patients (depending on CKD stage) [<a href="#pone.0202604.ref020" class="ref-tip">20</a>]. In another CKD cohort derived from the U.S. National Health and Nutrition Examination Survey 1996–2006, 48.5% of the participants exhibited controlled blood pressure (defined as blood pressure < 140/90 mmHg) [<a href="#pone.0202604.ref021" class="ref-tip">21</a>]. A cross-sectional survey of CKD patients in Spain found blood pressure levels < 140/90 mmHg in 45.5% of participants [<a href="#pone.0202604.ref022" class="ref-tip">22</a>]. Different inclusion criteria with regard to CKD stages or different settings for recruitment, visits and blood pressure measurements may contribute to the varying control rates.</p> <a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4" class="link-target"></a><p>Within our study higher age and male sex were associated with lower odds for a successful control of hypertension, as also described in other studies of CKD patients [<a href="#pone.0202604.ref013" class="ref-tip">13</a>, <a href="#pone.0202604.ref020" class="ref-tip">20</a>, <a href="#pone.0202604.ref023" class="ref-tip">23</a>]. The eGFR stratum (or the CKD stage, conversely) did not affect the odds for control of hypertension after adjustment for other variables, as also reported from the CRIC study [<a href="#pone.0202604.ref013" class="ref-tip">13</a>]. Other authors [<a href="#pone.0202604.ref020" class="ref-tip">20</a>], however, reported conflicting findings. Of particular concern is the lower control rate in patients with higher proteinuria in our and several other reports [<a href="#pone.0202604.ref013" class="ref-tip">13</a>, <a href="#pone.0202604.ref022" class="ref-tip">22</a>, <a href="#pone.0202604.ref023" class="ref-tip">23</a>], because these are the very patients who would presumably benefit most from a good control of blood pressure [<a href="#pone.0202604.ref005" class="ref-tip">5</a>]. Somewhat surprising to us was the clear and strong association of higher self-declared yearly gross income with better control of blood pressure. The association by itself was not unexpected, as described e.g. in the CRIC study [<a href="#pone.0202604.ref013" class="ref-tip">13</a>], but the relationship was clearly more marked as in CRIC, despite Germany’s mandatory universal health insurance [<a href="#pone.0202604.ref024" class="ref-tip">24</a>]. Please note that there were a significant number of patients for which we did not have information on annual gross income. We assume that some patients did not feel comfortable to reveal their level of income. All patients had access to nephrology specialist care (GCKD inclusion criterium) and blood pressure medications are provided at no costs or for small copayments. In Germany, the public discussion about differential access to health services has for years revolved around the type of health insurance (statutory insurance for most of the population versus private insurance for ~ 10%, mostly higher-income persons) [<a href="#pone.0202604.ref024" class="ref-tip">24</a>]. In this regard, it appears to be of note that the type of insurance (statutory versus private) did not affect the odds for control of blood pressure but income still did.</p> <a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5" class="link-target"></a><p>As awareness of hypertension and rates of pharmacological treatment were high, we investigated whether a high prevalence of treatment-resistant hypertension in our CKD patients may account for the low overall rates of controlled blood pressure. Our data show that approximately half of our patients with uncontrolled blood pressure had resistant hypertension. We used criteria for resistant hypertension adapted from the definition in the 2013 European Society of Hypertension / European Society of Cardiology hypertension guidelines [<a href="#pone.0202604.ref011" class="ref-tip">11</a>]: blood pressure ≥ 140 mmHg systolic or 90 mmHg diastolic despite at least 3 different antihypertensive medications, including a diuretic. A recent report from the CRIC study used a slightly different definition of “apparent treatment resistant hypertension” and demonstrated that resistant hypertension at enrolment was associated with increased mortality as well as elevated risks for cardiovascular and renal events [<a href="#pone.0202604.ref025" class="ref-tip">25</a>].</p> <a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6" class="link-target"></a><p>An important limitation of our study is that we collected information on the prescribed medications but not on the drug doses, intake schedules, or duration of treatment. Since we also did not assess the adherence to treatment, which is difficult to measure [<a href="#pone.0202604.ref026" class="ref-tip">26</a>], we cannot exclude that the actual drug intake may markedly fall short of the number of drugs prescribed [<a href="#pone.0202604.ref027" class="ref-tip">27</a>]. A previous questionnaire-based estimate of the adherence indicated that patients with CKD exhibited no better adherence regarding antihypertensive medications than hypertensive patients without CKD [<a href="#pone.0202604.ref028" class="ref-tip">28</a>]. Others have reported lower adherence with worsening GFR [<a href="#pone.0202604.ref029" class="ref-tip">29</a>]. On the other hand it is important to note that information on medication intake was directly obtained from patients during standardized interviews rather than from prescription information in health records or from the treating physicians, which may have reduced differences between medication information and actual intake. Nevertheless, our estimate of the frequency of resistant hypertension is likely to be biased by nonadherence [<a href="#pone.0202604.ref030" class="ref-tip">30</a>].</p> <a id="article1.body1.sec4.p7" name="article1.body1.sec4.p7" class="link-target"></a><p>Conversely, our results indicate that 49.0% of the patients with uncontrolled hypertension did not meet the definition of resistant hypertension. While this implies that there was room for use of more anti-hypertensive agents, the overall anti-hypertensive medication use was already substantial. More than 80% of the hypertensive patients received RAS inhibitors, as recommended by many guidelines [<a href="#pone.0202604.ref010" class="ref-tip">10</a>, <a href="#pone.0202604.ref011" class="ref-tip">11</a>]. The relatively high percentage of patients receiving aliskiren and/or double RAS blockade is probably due to the fact that the data were collected before the publication of the results of the ALTITUDE [<a href="#pone.0202604.ref031" class="ref-tip">31</a>] and VA-NEPHRON-D [<a href="#pone.0202604.ref032" class="ref-tip">32</a>] trials which cautioned against double RAS blockade. The frequency of use of RAS inhibitors as well as of other antihypertensive drug classes was broadly similar to the respective frequencies in CKD cohort studies from Spain [<a href="#pone.0202604.ref016" class="ref-tip">16</a>] and the U.S. [<a href="#pone.0202604.ref013" class="ref-tip">13</a>]. In contrast, a survey-based study of CKD patients identified from the U.S. National Health and Nutrition Examination Survey reported far lower frequencies of RAS blocker usage [<a href="#pone.0202604.ref033" class="ref-tip">33</a>], suggesting that the prescription of these drugs is associated with nephrology care. In our study as well as in CRIC [<a href="#pone.0202604.ref013" class="ref-tip">13</a>], use of RAS inhibitors was associated with better odds for blood pressure control. Several infrequently used drug classes were associated with a lower odds ratio for blood pressure control but this should not be misunderstood to imply a causal relationship. Presumably these drugs were mostly employed as third-line agents in patients with otherwise poorly controlled hypertension. Diuretics were used with similar frequencies in the CRIC cohort [<a href="#pone.0202604.ref013" class="ref-tip">13</a>] and in patients from the GCKD study, and were associated with better control of blood pressure. Again, this observation should not be construed to imply a cause-and-effect relationship; the design of our study does not permit such a conclusion.</p> <a id="article1.body1.sec4.p8" name="article1.body1.sec4.p8" class="link-target"></a><p>A further limitation of our study is the use of office blood pressure measurements obtained during a single visit, even though they were obtained in a highly standardized way. A study which compared office and 24 hour ambulatory blood pressure measurements in CKD patients from a large registry in Spain recorded disagreement between both measurements in a third of the patients [<a href="#pone.0202604.ref034" class="ref-tip">34</a>]. Similar results were recently reported from the CRIC study: only 4.1% of patients had controlled 24-hour ambulatory blood pressure but uncontrolled office blood pressure, i.e. “white-coat” hypertension, whereas no fewer than 27.8% exhibited “masked” hypertension, i.e. uncontrolled ambulatory blood pressure despite controlled office blood pressure [<a href="#pone.0202604.ref035" class="ref-tip">35</a>]. In light of these recent data, we speculate that the control of blood pressure in our patients may be even worse than our office blood pressure results would imply.</p> <a id="article1.body1.sec4.p9" name="article1.body1.sec4.p9" class="link-target"></a><p>In summary, our data clearly show that blood pressure control of CKD patients remains challenging even in the setting of nephrology specialist care, despite high rates of awareness and medication use. The fact that our observations are very similar to those in CRIC, a large, multi-ethnic cohort in the U.S. where patients were enrolled in large centers rather than small practices, indicates that this challenge exists independent of ethnicity, differences in environmental factors, health care coverage and treatment settings. Given that poorly controlled blood pressure is closely associated with progression of kidney disease as well as cardiovascular complications, intensified efforts to control blood pressure appear warranted.</p> </div> <div xmlns:plos="http://plos.org" class="section toc-section"><a id="ack" name="ack" data-toc="ack" title="Acknowledgments" class="link-target"></a><h2>Acknowledgments</h2> <a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1" class="link-target"></a><p>Current GCKD investigators are:</p> <a id="article1.back1.ack1.p2" name="article1.back1.ack1.p2" class="link-target"></a><p>University of Erlangen-Nürnberg: Kai-Uwe Eckardt, Heike Meiselbach, Markus P. Schneider, Thomas Dienemann, Hans-Ulrich Prokosch, Barbara Bärthlein, André Reis, Arif B. Ekici, Olaf Gefeller, Silvia Hübner, Susanne Avendaño, Dinah Becker-Grosspitsch, Birgit Hausknecht, Rita Zitzmann, Anke Weigel, Andreas Beck, Thomas Ganslandt, Sabine Knispel</p> <a id="article1.back1.ack1.p3" name="article1.back1.ack1.p3" class="link-target"></a><p>University of Freiburg: Gerd Walz, Anna Köttgen, Ulla Schultheiß, Simone Meder, Erna Mitsch, Ursula Reinhard</p> <a id="article1.back1.ack1.p4" name="article1.back1.ack1.p4" class="link-target"></a><p>RWTH Aachen University: Jürgen Floege, Georg Schlieper, Turgay Saritas, Sabine Ernst, Astrid Blasius, Kerstin Schmitz</p> <a id="article1.back1.ack1.p5" name="article1.back1.ack1.p5" class="link-target"></a><p>Charité, University Medicine Berlin: Elke Schaeffner, Seema Baid-Agrawal, Kerstin Theisen</p> <a id="article1.back1.ack1.p6" name="article1.back1.ack1.p6" class="link-target"></a><p>Hannover Medical School: Hermann Haller, Jan Menne, Johan Lorenzen, Elisabeth Bahlmann, Manina Bogdahn</p> <a id="article1.back1.ack1.p7" name="article1.back1.ack1.p7" class="link-target"></a><p>University of Heidelberg: Martin Zeier, Claudia Sommerer, Claudia Föllinger</p> <a id="article1.back1.ack1.p8" name="article1.back1.ack1.p8" class="link-target"></a><p>University of Jena: Gunter Wolf, Martin Busch, Rainer Fuß</p> <a id="article1.back1.ack1.p9" name="article1.back1.ack1.p9" class="link-target"></a><p>Ludwig-Maximilians University of München: Thomas Sitter, Claudia Blank</p> <a id="article1.back1.ack1.p10" name="article1.back1.ack1.p10" class="link-target"></a><p>University of Würzburg: Christoph Wanner, Vera Krane, Karina Schönowsky, Antje Börner-Klein</p> <a id="article1.back1.ack1.p11" name="article1.back1.ack1.p11" class="link-target"></a><p>Medical University of Innsbruck, Division of Genetic Epidemiology: Florian Kronenberg, Julia Raschenberger, Barbara Kollerits, Lukas Forer, Sebastian Schönherr, Hansi Weissensteiner</p> <a id="article1.back1.ack1.p12" name="article1.back1.ack1.p12" class="link-target"></a><p>University of Regensburg, Institute of Functional Genomics: Peter Oefner, Wolfram Gronwald, Helena Zacharias</p> <a id="article1.back1.ack1.p13" name="article1.back1.ack1.p13" class="link-target"></a><p>University of Bonn, Department of Medical Biometry, Informatics and Epidemiology (IMBIE): Matthias Schmid, Jennifer Nadal.</p> </div><div xmlns:plos="http://plos.org" class="toc-section"><a id="references" name="references" class="link-target" data-toc="references" title="References"></a><h2>References</h2><ol class="references"><li id="ref1"><span class="order">1. </span><a name="pone.0202604.ref001" id="pone.0202604.ref001" class="link-target"></a>Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158–69. pmid:23727165. <ul class="reflinks" data-doi="10.1016/S0140-6736(13)60439-0"><li><a href="https://doi.org/10.1016/S0140-6736(13)60439-0" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23727165" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Evolving+importance+of+kidney+disease%3A+from+subspecialty+to+global+health+burden+Eckardt+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref2"><span class="order">2. </span><a name="pone.0202604.ref002" id="pone.0202604.ref002" class="link-target"></a>Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–80. pmid:21840587. <ul class="reflinks" data-doi="10.1016/S0140-6736(11)60178-5"><li><a href="https://doi.org/10.1016/S0140-6736(11)60178-5" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21840587" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Chronic+kidney+disease+Levey+2012" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref3"><span class="order">3. </span><a name="pone.0202604.ref003" id="pone.0202604.ref003" class="link-target"></a>Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52. pmid:23727170. <ul class="reflinks" data-doi="10.1016/S0140-6736(13)60595-4"><li><a href="https://doi.org/10.1016/S0140-6736(13)60595-4" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23727170" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Chronic+kidney+disease+and+cardiovascular+risk%3A+epidemiology%2C+mechanisms%2C+and+prevention+Gansevoort+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref4"><span class="order">4. </span><a name="pone.0202604.ref004" id="pone.0202604.ref004" class="link-target"></a>Rossignol P, Massy ZA, Azizi M, Bakris G, Ritz E, Covic A, et al. The double challenge of resistant hypertension and chronic kidney disease. Lancet. 2015;386(10003):1588–98. pmid:26530623. <ul class="reflinks" data-doi="10.1016/S0140-6736(15)00418-3"><li><a href="https://doi.org/10.1016/S0140-6736(15)00418-3" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/26530623" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=The+double+challenge+of+resistant+hypertension+and+chronic+kidney+disease+Rossignol+2015" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref5"><span class="order">5. </span><a name="pone.0202604.ref005" id="pone.0202604.ref005" class="link-target"></a>Schneider MP, Hilgers KF. What should be the goal blood pressure in nondiabetic chronic kidney disease? Current opinion in nephrology and hypertension. 2014;23(2):180–5. pmid:24401787. <ul class="reflinks" data-doi="10.1097/01.mnh.0000441050.36783.ba"><li><a href="https://doi.org/10.1097/01.mnh.0000441050.36783.ba" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/24401787" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=What+should+be+the+goal+blood+pressure+in+nondiabetic+chronic+kidney+disease%3F+Schneider+2014" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref6"><span class="order">6. </span><a name="pone.0202604.ref006" id="pone.0202604.ref006" class="link-target"></a>Wheeler DC, Becker GJ. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney international. 2013;83(3):377–83. pmid:23325075. <ul class="reflinks" data-doi="10.1038/ki.2012.425"><li><a href="https://doi.org/10.1038/ki.2012.425" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23325075" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Summary+of+KDIGO+guideline.+What+do+we+really+know+about+management+of+blood+pressure+in+patients+with+chronic+kidney+disease+Wheeler+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref7"><span class="order">7. </span><a name="pone.0202604.ref007" id="pone.0202604.ref007" class="link-target"></a>Group SR, Wright JT Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England journal of medicine. 2015;373(22):2103–16. pmid:26551272; PubMed Central PMCID: PMC4689591. <ul class="reflinks" data-doi="10.1056/NEJMoa1511939"><li><a href="https://doi.org/10.1056/NEJMoa1511939" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/26551272" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=A+Randomized+Trial+of+Intensive+versus+Standard+Blood-Pressure+Control+Group+2015" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref8"><span class="order">8. </span><a name="pone.0202604.ref008" id="pone.0202604.ref008" class="link-target"></a>Chertow GM, Beddhu S, Lewis JB, Toto RD, Cheung AK. Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT. Journal of the American Society of Nephrology: JASN. 2016;27(1):40–3. pmid:26553785; PubMed Central PMCID: PMC4696594. <ul class="reflinks" data-doi="10.1681/ASN.2015101125"><li><a href="https://doi.org/10.1681/ASN.2015101125" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/26553785" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Managing+Hypertension+in+Patients+with+CKD%3A+A+Marathon%2C+Not+a+SPRINT+Chertow+2016" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref9"><span class="order">9. </span><a name="pone.0202604.ref009" id="pone.0202604.ref009" class="link-target"></a>Taler SJ. How Does SPRINT (Systolic Blood Pressure Intervention Trial) Direct Hypertension Treatment Targets for CKD? American journal of kidney diseases: the official journal of the National Kidney Foundation. 2016. pmid:27012910. <ul class="reflinks" data-doi="10.1053/j.ajkd.2016.02.045"><li><a href="https://doi.org/10.1053/j.ajkd.2016.02.045" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/27012910" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=How+Does+SPRINT+%28Systolic+Blood+Pressure+Intervention+Trial%29+Direct+Hypertension+Treatment+Targets+for+CKD%3F+Taler+2016" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref10"><span class="order">10. </span><a name="pone.0202604.ref010" id="pone.0202604.ref010" class="link-target"></a>Group KBPW. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337–414. <ul class="reflinks"><li><a href="#" data-author="Group" data-cit="GroupKBPW.%20KDIGO%20clinical%20practice%20guideline%20for%20the%20management%20of%20blood%20pressure%20in%20chronic%20kidney%20disease.%20Kidney%20Int%20Suppl.%202012%3B2%3A337%E2%80%93414." data-title="KDIGO%20clinical%20practice%20guideline%20for%20the%20management%20of%20blood%20pressure%20in%20chronic%20kidney%20disease" target="_new" title="Go to article in CrossRef"> View Article </a></li><li><a href="http://scholar.google.com/scholar?q=KDIGO+clinical+practice+guideline+for+the+management+of+blood+pressure+in+chronic+kidney+disease+Group+2012" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref11"><span class="order">11. </span><a name="pone.0202604.ref011" id="pone.0202604.ref011" class="link-target"></a>Hypertension EETFftMoA. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. Journal of hypertension. 2013;31(10):1925–38. pmid:24107724. <ul class="reflinks" data-doi="10.1097/HJH.0b013e328364ca4c"><li><a href="https://doi.org/10.1097/HJH.0b013e328364ca4c" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/24107724" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Practice+guidelines+for+the+management+of+arterial+hypertension+of+the+European+Society+of+Hypertension+%28ESH%29+and+the+European+Society+of+Cardiology+%28ESC%29%3A+ESH%2FESC+Task+Force+for+the+Management+of+Arterial+Hypertension++2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref12"><span class="order">12. </span><a name="pone.0202604.ref012" id="pone.0202604.ref012" class="link-target"></a>James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014;311(5):507–20. pmid:24352797. <ul class="reflinks" data-doi="10.1001/jama.2013.284427"><li><a href="https://doi.org/10.1001/jama.2013.284427" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/24352797" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=2014+evidence-based+guideline+for+the+management+of+high+blood+pressure+in+adults%3A+report+from+the+panel+members+appointed+to+the+Eighth+Joint+National+Committee+%28JNC+8%29+James+2014" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref13"><span class="order">13. </span><a name="pone.0202604.ref013" id="pone.0202604.ref013" class="link-target"></a>Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010;55(3):441–51. pmid:19962808; PubMed Central PMCID: PMC2866514. <ul class="reflinks" data-doi="10.1053/j.ajkd.2009.09.014"><li><a href="https://doi.org/10.1053/j.ajkd.2009.09.014" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19962808" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Hypertension+awareness%2C+treatment%2C+and+control+in+adults+with+CKD%3A+results+from+the+Chronic+Renal+Insufficiency+Cohort+%28CRIC%29+Study+Muntner+2010" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref14"><span class="order">14. </span><a name="pone.0202604.ref014" id="pone.0202604.ref014" class="link-target"></a>Peralta CA, Hicks LS, Chertow GM, Ayanian JZ, Vittinghoff E, Lin F, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45(6):1119–24. pmid:15851626. <ul class="reflinks" data-doi="10.1161/01.HYP.0000164577.81087.70"><li><a href="https://doi.org/10.1161/01.HYP.0000164577.81087.70" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/15851626" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Control+of+hypertension+in+adults+with+chronic+kidney+disease+in+the+United+States+Peralta+2005" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref15"><span class="order">15. </span><a name="pone.0202604.ref015" id="pone.0202604.ref015" class="link-target"></a>Landray MJ, Emberson JR, Blackwell L, Dasgupta T, Zakeri R, Morgan MD, et al. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010;56(6):1082–94. pmid:21035932; PubMed Central PMCID: PMC2991589. <ul class="reflinks" data-doi="10.1053/j.ajkd.2010.07.016"><li><a href="https://doi.org/10.1053/j.ajkd.2010.07.016" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21035932" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Prediction+of+ESRD+and+death+among+people+with+CKD%3A+the+Chronic+Renal+Impairment+in+Birmingham+%28CRIB%29+prospective+cohort+study+Landray+2010" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref16"><span class="order">16. </span><a name="pone.0202604.ref016" id="pone.0202604.ref016" class="link-target"></a>Martinez-Castelao A, Gorriz JL, Portoles JM, De Alvaro F, Cases A, Luno J, et al. Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study. BMC nephrology. 2011;12:53. pmid:21970625; PubMed Central PMCID: PMC3203029. <ul class="reflinks" data-doi="10.1186/1471-2369-12-53"><li><a href="https://doi.org/10.1186/1471-2369-12-53" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21970625" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Baseline+characteristics+of+patients+with+chronic+kidney+disease+stage+3+and+stage+4+in+Spain%3A+the+MERENA+observational+cohort+study+Martinez-Castelao+2011" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref17"><span class="order">17. </span><a name="pone.0202604.ref017" id="pone.0202604.ref017" class="link-target"></a>Eckardt KU, Barthlein B, Baid-Agrawal S, Beck A, Busch M, Eitner F, et al. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2012;27(4):1454–60. pmid:21862458. <ul class="reflinks" data-doi="10.1093/ndt/gfr456"><li><a href="https://doi.org/10.1093/ndt/gfr456" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21862458" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=The+German+Chronic+Kidney+Disease+%28GCKD%29+study%3A+design+and+methods+Eckardt+2012" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref18"><span class="order">18. </span><a name="pone.0202604.ref018" id="pone.0202604.ref018" class="link-target"></a>Titze S, Schmid M, Kottgen A, Busch M, Floege J, Wanner C, et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2015;30(3):441–51. pmid:25271006. <ul class="reflinks" data-doi="10.1093/ndt/gfu294"><li><a href="https://doi.org/10.1093/ndt/gfu294" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/25271006" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Disease+burden+and+risk+profile+in+referred+patients+with+moderate+chronic+kidney+disease%3A+composition+of+the+German+Chronic+Kidney+Disease+%28GCKD%29+cohort+Titze+2015" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref19"><span class="order">19. </span><a name="pone.0202604.ref019" id="pone.0202604.ref019" class="link-target"></a>Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, et al. Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clinical and experimental nephrology. 2010;14(6):558–70. pmid:20700621. <ul class="reflinks" data-doi="10.1007/s10157-010-0328-6"><li><a href="https://doi.org/10.1007/s10157-010-0328-6" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20700621" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Chronic+Kidney+Disease+Japan+Cohort+study%3A+baseline+characteristics+and+factors+associated+with+causative+diseases+and+renal+function+Imai+2010" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref20"><span class="order">20. </span><a name="pone.0202604.ref020" id="pone.0202604.ref020" class="link-target"></a>Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ, et al. Hypertension awareness, treatment, and control in chronic kidney disease. The American journal of medicine. 2008;121(4):332–40. pmid:18374693. <ul class="reflinks" data-doi="10.1016/j.amjmed.2007.11.025"><li><a href="https://doi.org/10.1016/j.amjmed.2007.11.025" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/18374693" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Hypertension+awareness%2C+treatment%2C+and+control+in+chronic+kidney+disease+Sarafidis+2008" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref21"><span class="order">21. </span><a name="pone.0202604.ref021" id="pone.0202604.ref021" class="link-target"></a>Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flowers N, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006. Hypertension. 2009;54(1):47–56. pmid:19470881; PubMed Central PMCID: PMC2720323. <ul class="reflinks" data-doi="10.1161/HYPERTENSIONAHA.109.129841"><li><a href="https://doi.org/10.1161/HYPERTENSIONAHA.109.129841" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/19470881" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Blood+pressure+control+among+persons+without+and+with+chronic+kidney+disease%3A+US+trends+and+risk+factors+1999%E2%80%932006+Plantinga+2009" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref22"><span class="order">22. </span><a name="pone.0202604.ref022" id="pone.0202604.ref022" class="link-target"></a>Marin R, Fernandez-Vega F, Gorostidi M, Ruilope LM, Diez J, Praga M, et al. Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study. Journal of hypertension. 2006;24(2):395–402. pmid:16508589. <ul class="reflinks" data-doi="10.1097/01.hjh.0000202819.48577.a1"><li><a href="https://doi.org/10.1097/01.hjh.0000202819.48577.a1" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/16508589" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Blood+pressure+control+in+patients+with+chronic+renal+insufficiency+in+Spain%3A+a+cross-sectional+study+Marin+2006" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref23"><span class="order">23. </span><a name="pone.0202604.ref023" id="pone.0202604.ref023" class="link-target"></a>Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, et al. Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort. American journal of hypertension. 2012;25(3):342–7. pmid:22089103. <ul class="reflinks" data-doi="10.1038/ajh.2011.217"><li><a href="https://doi.org/10.1038/ajh.2011.217" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/22089103" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Blood+pressure+control+in+a+Japanese+population+with+chronic+kidney+disease%3A+a+baseline+survey+of+a+nationwide+cohort+Konta+2012" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref24"><span class="order">24. </span><a name="pone.0202604.ref024" id="pone.0202604.ref024" class="link-target"></a>Busse R, Blumel M. Germany: Health system review. Health systems in transition. 2014;16(2):1–296, xxi. pmid:25115137. <ul class="reflinks"><li><a href="#" data-author="Busse" data-cit="BusseR%2C%20BlumelM.%20Germany%3A%20Health%20system%20review.%20Health%20systems%20in%20transition.%202014%3B16%282%29%3A1%E2%80%93296%2C%20xxi.%2025115137." data-title="Germany%3A%20Health%20system%20review" target="_new" title="Go to article in CrossRef"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/25115137" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Germany%3A+Health+system+review+Busse+2014" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref25"><span class="order">25. </span><a name="pone.0202604.ref025" id="pone.0202604.ref025" class="link-target"></a>Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, et al. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study. Hypertension. 2016;67(2):387–96. pmid:26711738; PubMed Central PMCID: PMC4713320. <ul class="reflinks" data-doi="10.1161/HYPERTENSIONAHA.115.06487"><li><a href="https://doi.org/10.1161/HYPERTENSIONAHA.115.06487" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/26711738" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Prevalence+and+Prognostic+Significance+of+Apparent+Treatment+Resistant+Hypertension+in+Chronic+Kidney+Disease%3A+Report+From+the+Chronic+Renal+Insufficiency+Cohort+Study+Thomas+2016" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref26"><span class="order">26. </span><a name="pone.0202604.ref026" id="pone.0202604.ref026" class="link-target"></a>Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218–25. pmid:23753412. <ul class="reflinks" data-doi="10.1161/HYPERTENSIONAHA.113.00687"><li><a href="https://doi.org/10.1161/HYPERTENSIONAHA.113.00687" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23753412" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Measuring%2C+analyzing%2C+and+managing+drug+adherence+in+resistant+hypertension+Burnier+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref27"><span class="order">27. </span><a name="pone.0202604.ref027" id="pone.0202604.ref027" class="link-target"></a>Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. Journal of hypertension. 2013;31(4):766–74. pmid:23337469. <ul class="reflinks" data-doi="10.1097/HJH.0b013e32835e2286"><li><a href="https://doi.org/10.1097/HJH.0b013e32835e2286" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23337469" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Resistant+hypertension%3F+Assessment+of+adherence+by+toxicological+urine+analysis+Jung+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref28"><span class="order">28. </span><a name="pone.0202604.ref028" id="pone.0202604.ref028" class="link-target"></a>Muntner P, Judd SE, Krousel-Wood M, McClellan WM, Safford MM. Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010;56(3):447–57. pmid:20471734; PubMed Central PMCID: PMC3659158. <ul class="reflinks" data-doi="10.1053/j.ajkd.2010.02.348"><li><a href="https://doi.org/10.1053/j.ajkd.2010.02.348" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/20471734" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Low+medication+adherence+and+hypertension+control+among+adults+with+CKD%3A+data+from+the+REGARDS+%28Reasons+for+Geographic+and+Racial+Differences+in+Stroke%29+Study+Muntner+2010" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref29"><span class="order">29. </span><a name="pone.0202604.ref029" id="pone.0202604.ref029" class="link-target"></a>Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. American journal of nephrology. 2010;32(6):541–8. pmid:21042012. <ul class="reflinks" data-doi="10.1159/000321688"><li><a href="https://doi.org/10.1159/000321688" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21042012" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Adherence+to+antihypertensive+agents+and+blood+pressure+control+in+chronic+kidney+disease+Schmitt+2010" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref30"><span class="order">30. </span><a name="pone.0202604.ref030" id="pone.0202604.ref030" class="link-target"></a>Burnier M, Pruijm M, Wuerzner G, Santschi V. Drug adherence in chronic kidney diseases and dialysis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2015;30(1):39–44. pmid:24516224. <ul class="reflinks" data-doi="10.1093/ndt/gfu015"><li><a href="https://doi.org/10.1093/ndt/gfu015" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/24516224" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Drug+adherence+in+chronic+kidney+diseases+and+dialysis+Burnier+2015" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref31"><span class="order">31. </span><a name="pone.0202604.ref031" id="pone.0202604.ref031" class="link-target"></a>Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. The New England journal of medicine. 2012;367(23):2204–13. pmid:23121378. <ul class="reflinks" data-doi="10.1056/NEJMoa1208799"><li><a href="https://doi.org/10.1056/NEJMoa1208799" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23121378" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Cardiorenal+end+points+in+a+trial+of+aliskiren+for+type+2+diabetes+Parving+2012" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref32"><span class="order">32. </span><a name="pone.0202604.ref032" id="pone.0202604.ref032" class="link-target"></a>Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. The New England journal of medicine. 2013;369(20):1892–903. pmid:24206457. <ul class="reflinks" data-doi="10.1056/NEJMoa1303154"><li><a href="https://doi.org/10.1056/NEJMoa1303154" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/24206457" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Combined+angiotensin+inhibition+for+the+treatment+of+diabetic+nephropathy+Fried+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref33"><span class="order">33. </span><a name="pone.0202604.ref033" id="pone.0202604.ref033" class="link-target"></a>Sonawane KB, Qian J, Hansen RA. Utilization patterns of antihypertensive drugs among the chronic kidney disease population in the United States: a cross-sectional analysis of the national health and nutrition examination survey. Clinical therapeutics. 2015;37(1):188–96. pmid:25524390. <ul class="reflinks" data-doi="10.1016/j.clinthera.2014.11.011"><li><a href="https://doi.org/10.1016/j.clinthera.2014.11.011" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/25524390" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Utilization+patterns+of+antihypertensive+drugs+among+the+chronic+kidney+disease+population+in+the+United+States%3A+a+cross-sectional+analysis+of+the+national+health+and+nutrition+examination+survey+Sonawane+2015" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref34"><span class="order">34. </span><a name="pone.0202604.ref034" id="pone.0202604.ref034" class="link-target"></a>Gorostidi M, Sarafidis PA, de la Sierra A, Segura J, de la Cruz JJ, Banegas JR, et al. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2013;62(2):285–94. pmid:23689071. <ul class="reflinks" data-doi="10.1053/j.ajkd.2013.03.025"><li><a href="https://doi.org/10.1053/j.ajkd.2013.03.025" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/23689071" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Differences+between+office+and+24-hour+blood+pressure+control+in+hypertensive+patients+with+CKD%3A+A+5%2C693-patient+cross-sectional+analysis+from+Spain.+American+journal+of+kidney+diseases%3A+the+official+journal+of+the+Gorostidi+2013" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li><li id="ref35"><span class="order">35. </span><a name="pone.0202604.ref035" id="pone.0202604.ref035" class="link-target"></a>Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, et al. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. Clinical journal of the American Society of Nephrology: CJASN. 2016. pmid:26912547. <ul class="reflinks" data-doi="10.2215/CJN.08530815"><li><a href="https://doi.org/10.2215/CJN.08530815" data-author="doi-provided" data-cit="doi-provided" data-title="doi-provided" target="_new" title="Go to article"> View Article </a></li><li><a href="http://www.ncbi.nlm.nih.gov/pubmed/26912547" target="_new" title="Go to article in PubMed"> PubMed/NCBI </a></li><li><a href="http://scholar.google.com/scholar?q=Masked+Hypertension+and+Elevated+Nighttime+Blood+Pressure+in+CKD%3A+Prevalence+and+Association+with+Target+Organ+Damage+Drawz+2016" target="_new" title="Go to article in Google Scholar"> Google Scholar </a></li></ul></li></ol></div> <div class="ref-tooltip"> <div class="ref_tooltip-content"> </div> </div> </div> </div> </div> </section> <aside class="article-aside">  <div class="dload-menu"> <div class="dload-pdf"> <a href="/plosone/article/file?id=10.1371/journal.pone.0202604&type=printable" id="downloadPdf" target="_blank">Download PDF</a> </div> <div data-js-tooltip-hover="trigger" class="dload-hover">  <ul class="dload-xml" data-js-tooltip-hover="target"> <li><a href="/plosone/article/citation?id=10.1371/journal.pone.0202604" id="downloadCitation">Citation</a></li> <li><a href="/plosone/article/file?id=10.1371/journal.pone.0202604&type=manuscript" id="downloadXml">XML</a> </li> </ul> </div> </div> <div class="aside-container"> <div class="print-article" id="printArticle" data-js-tooltip-hover="trigger"> <a href="#" onclick="window.print(); return false;" class="preventDefault" id="printBrowser">Print</a> </div> <div class="share-article" id="shareArticle" data-js-tooltip-hover="trigger"> Share <ul data-js-tooltip-hover="target" class="share-options" id="share-options"> <li><a href="https://www.reddit.com/submit?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0202604" id="shareReddit" target="_blank" title="Submit to Reddit"><img src="/resource/img/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li> <li><a href="https://www.facebook.com/share.php?u=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0202604&t=Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study" id="shareFacebook" target="_blank" title="Share on Facebook"><img src="/resource/img/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li> <li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0202604&title=Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study&summary=Checkout this article I found at PLOS" id="shareLinkedIn" target="_blank" title="Add to LinkedIn"><img src="/resource/img/icon.linkedin.16.png" width="16" height="16" alt="LinkedIn">LinkedIn</a></li> <li><a href="https://www.mendeley.com/import/?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0202604" id="shareMendeley" target="_blank" title="Add to Mendeley"><img src="/resource/img/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li> <li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0202604&text=%23PLOSONE%3A%20Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study" target="_blank" title="share on Twitter" id="twitter-share-link"><img src="/resource/img/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li> <li><a href="mailto:?subject=Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study&body=I%20thought%20you%20would%20find%20this%20article%20interesting.%20From%20PLOS ONE:%20https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0202604" id="shareEmail" rel="noreferrer" aria-label="Email"><img src="/resource/img/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li> <script src="/resource/js/components/tweet140.js" type="text/javascript"></script> </ul> </div> </div>  <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a aria-label="Check for updates via CrossMark" data-target="crossmark"> <img alt="Check for updates via CrossMark" width="150" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_BW_horizontal.svg"> </a>  <div class="related-articles-container"> <h3> Related PLOS Articles </h3> <ul class="related-articles"> <li> <b> has CORRECTION </b> </li> <li> <?xml version="1.0" encoding="UTF-8"?>Correction: Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study <ul class="related-article-links"> <li class="related-article-link-page"> <a href="/plosone/article?id=10.1371/journal.pone.0204340">View Page</a> </li>  <li class="related-article-link-download"> <a href="/plosone/article/file?type=printable&id=10.1371/journal.pone.0204340" target="_blank" title="PDF opens in new window">PDF</a> </li> </ul> </li> </ul> </div> <div class="aside-container collections-aside-container"></div> <div class="skyscraper-container"> <div class="title">Advertisement</div>  <div class='advertisement' id='div-gpt-ad-1458247671871-1' style='width:160px; height:600px;'> <script type='text/javascript'> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-1'); }); </script> </div> </div> <div class="subject-areas-container"> <h3>Subject Areas <div id="subjInfo">?</div> <div id="subjInfoText"> <p>For more information about PLOS Subject Areas, click <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.</p> <span class="inline-intro">We want your feedback.</span> Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help! </div> </h3> <ul id="subjectList"> <li> <a class="taxo-term" title="Search for articles about Blood pressure" href="/plosone/search?filterSubjects=Blood+pressure&filterJournals=PLoSONE&q=">Blood pressure</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Blood pressure"><p class="taxo-explain">Is the Subject Area <strong>"Blood pressure"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Hypertension" href="/plosone/search?filterSubjects=Hypertension&filterJournals=PLoSONE&q=">Hypertension</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Hypertension"><p class="taxo-explain">Is the Subject Area <strong>"Hypertension"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Chronic kidney disease" href="/plosone/search?filterSubjects=Chronic+kidney+disease&filterJournals=PLoSONE&q=">Chronic kidney disease</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Chronic kidney disease"><p class="taxo-explain">Is the Subject Area <strong>"Chronic kidney disease"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Antihypertensives" href="/plosone/search?filterSubjects=Antihypertensives&filterJournals=PLoSONE&q=">Antihypertensives</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Antihypertensives"><p class="taxo-explain">Is the Subject Area <strong>"Antihypertensives"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Nephrology" href="/plosone/search?filterSubjects=Nephrology&filterJournals=PLoSONE&q=">Nephrology</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Nephrology"><p class="taxo-explain">Is the Subject Area <strong>"Nephrology"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Diuretics" href="/plosone/search?filterSubjects=Diuretics&filterJournals=PLoSONE&q=">Diuretics</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Diuretics"><p class="taxo-explain">Is the Subject Area <strong>"Diuretics"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Resistant hypertension" href="/plosone/search?filterSubjects=Resistant+hypertension&filterJournals=PLoSONE&q=">Resistant hypertension</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Resistant hypertension"><p class="taxo-explain">Is the Subject Area <strong>"Resistant hypertension"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> <li> <a class="taxo-term" title="Search for articles about Antihypertensive drugs" href="/plosone/search?filterSubjects=Antihypertensive+drugs&filterJournals=PLoSONE&q=">Antihypertensive drugs</a> <span class="taxo-flag"> </span> <div class="taxo-tooltip" data-categoryname="Antihypertensive drugs"><p class="taxo-explain">Is the Subject Area <strong>"Antihypertensive drugs"</strong> applicable to this article? <button id="noFlag" data-action="remove">Yes</button> <button id="flagIt" value="flagno" data-action="add">No</button></p> <p class="taxo-confirm">Thanks for your feedback.</p> </div> </li> </ul> </div> <div id="subjectErrors"></div> </aside> </div> </main> <footer id="pageftr"> <div class="row"> <div class="block x-small"> <ul class="nav nav-secondary"> <li class="ftr-header"><a href="https://plos.org/publications/journals/">Publications</a></li> <li><a href="/plosbiology/" id="ftr-bio">PLOS Biology</a></li> <li><a href="/climate/" id="ftr-climate">PLOS Climate</a></li> <li><a href="/complexsystems/" id="ftr-complex-systems">PLOS Complex Systems</a></li> <li><a href="/ploscompbiol/" id="ftr-compbio">PLOS Computational Biology</a></li> <li><a href="/digitalhealth/" id="ftr-digitalhealth">PLOS Digital Health</a></li> <li><a href="/plosgenetics/" id="ftr-gen">PLOS Genetics</a></li> <li><a href="/globalpublichealth/" id="ftr-globalpublichealth">PLOS Global Public Health</a></li> </ul> </div> <div class="block x-small"> <ul class="nav nav-secondary"> <li class="ftr-header"> </li> <li><a href="/plosmedicine/" id="ftr-med">PLOS Medicine</a></li> <li><a href="/mentalhealth/" id="ftr-mental-health">PLOS Mental Health</a></li> <li><a href="/plosntds/" id="ftr-ntds">PLOS Neglected Tropical Diseases</a></li> <li><a href="/plosone/" id="ftr-one">PLOS ONE</a></li> <li><a href="/plospathogens/" id="ftr-path">PLOS Pathogens</a></li> <li><a href="/sustainabilitytransformation/" id="ftr-sustainabilitytransformation">PLOS Sustainability and Transformation</a></li> <li><a href="/water/" id="ftr-water">PLOS Water</a></li> </ul> </div> <div class="block xx-small"> <ul class="nav nav-tertiary"> <li> <a href="https://plos.org" id="ftr-home">Home</a> </li> <li> <a href="https://blogs.plos.org" id="ftr-blog">Blogs</a> </li> <li> <a href="https://collections.plos.org/" id="ftr-collections">Collections</a> </li> <li> <a href="mailto:webmaster@plos.org" id="ftr-feedback">Give feedback</a> </li> <li> <a href="/plosone/lockss-manifest" id="ftr-lockss">LOCKSS</a> </li> </ul> </div> <div class="block xx-small"> <ul class="nav nav-primary"> <li><a href="https://plos.org/privacy-policy" id="ftr-privacy">Privacy Policy</a></li> <li><a href="https://plos.org/terms-of-use" id="ftr-terms">Terms of Use</a></li> <li><a href="https://plos.org/advertise/" id="ftr-advertise">Advertise</a></li> <li><a href="https://plos.org/media-inquiries" id="ftr-media">Media Inquiries</a></li> <li><a href="https://plos.org/contact" id="ftr-contact">Contact</a></li> </ul> </div> </div> <div class="row"> <p> <img src="/resource/img/logo-plos-footer.png" alt="PLOS" class="logo-footer"/> <span class="footer-non-profit-statement">PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US</span> </p> <div class="block"> </div> </div> <script src="/resource/js/global.js" type="text/javascript"></script> </footer> <script type="text/javascript"> var ArticleData = { doi: '10.1371/journal.pone.0202604', title: '<article-title xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study<\/article-title>', date: 'Aug 20, 2018' }; </script> <script src="/resource/js/components/show_onscroll.js" type="text/javascript"></script> <script src="/resource/js/components/pagination.js" type="text/javascript"></script> <script src="/resource/js/vendor/spin.js" type="text/javascript"></script> <script src="/resource/js/pages/article.js" type="text/javascript"></script> <script src="/resource/js/pages/article_references.js" type="text/javascript"></script> <script src="/resource/js/pages/article_sidebar.js" type="text/javascript"></script> <script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script> <script src="/resource/js/components/table_open.js" type="text/javascript"></script> <script src="/resource/js/components/figshare.js" type="text/javascript"></script> <script src="/resource/js/vendor/jquery.panzoom.min.js" type="text/javascript"></script> <script src="/resource/js/vendor/jquery.mousewheel.js" type="text/javascript"></script> <script src="/resource/js/components/lightbox.js" type="text/javascript"></script> <script src="/resource/js/pages/article_body.js" type="text/javascript"></script>    <script type="text/x-mathjax-config"> MathJax.Hub.Config({ "HTML-CSS": { scale: 100, availableFonts: ["STIX","TeX"], preferredFont: "STIX", webFont: "STIX-Web", linebreaks: { automatic: false } }, jax: ["input/MathML", "output/HTML-CSS"] }); </script> <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=MML_HTMLorMML"></script> <div class="reveal-modal-bg"></div> </body> </html>